Propanc Biopharma (PPCB) 10-Q 16 May 16 2016 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Mar. 31, 2016	May. 11, 2016
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2016
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q3
Entity Registrant Name	Propanc Health Group Corp
Entity Central Index Key	1,517,681
Current Fiscal Year End Date	--06-30
Entity Filer Category	Smaller Reporting Company
Trading Symbol	PPCH
Entity Common Stock, Shares Outstanding		721,929,520

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2016	Jun. 30, 2015
CURRENT ASSETS:
Cash	$ 1,479,026	$ 107,627
GST tax receivable	21,628	11,647
Prepaid expenses and other current assets	117,096	502,616
TOTAL CURRENT ASSETS	1,617,750	621,890
Security deposit	1,687	1,684
Property and equipment, net	3,678	3,494
TOTAL ASSETS	1,623,115	627,068
CURRENT LIABILITIES:
Accounts payable	159,323	236,466
Accrued expenses and other payables	60,627	386,311
Convertible notes and related accrued interest, net	999,089	1,794,375
Loans payable	2,300	27,558
Embedded conversion option liabilities	3,659,506	780,281
Warrant derivative liability	80,630	269,648
Due to directors - related parties	35,168	35,108
Loans from directors and officer - related parties	56,743	79,416
Employee benefit liability	90,602	71,421
TOTAL CURRENT LIABILITIES	$ 5,143,988	$ 3,680,584
Commitments and Contingencies (See Note 7)
STOCKHOLDERS' DEFICIT:
Common stock, $0.001 par value; 2,000,000,000 shares authorized; 602,454,054 and 347,442,013 shares issued and outstanding as of March 31, 2016 and June 30, 2015, respectively	$ 602,455	$ 347,442
Additional paid-in capital	23,415,658	17,458,745
Accumulated other comprehensive income (loss)	(25,445)	100,968
Accumulated deficit	(27,518,541)	(20,965,671)
TOTAL STOCKHOLDERS' DEFICIT	(3,520,873)	(3,053,516)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	1,623,115	627,068
Series A Preferred Stock [Member]
STOCKHOLDERS' DEFICIT:
Preferred stock value	5,000	5,000
Series B Preferred Stock [Member]
STOCKHOLDERS' DEFICIT:
Preferred stock value	$ 0	$ 0

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2016	Jun. 30, 2015
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, authorized shares	2,000,000,000	2,000,000,000
Common stock, issued shares	602,454,054	347,442,013
Common stock, outstanding shares	602,454,054	347,442,013
Series A Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, authorized shares	10,000,000	10,000,000
Preferred stock, issued shares	500,000	500,000
Preferred stock, outstanding shares	500,000	500,000
Series B Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, authorized shares	5	5
Preferred stock, issued shares	1	1
Preferred stock, outstanding shares	1	1

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME (LOSS) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Mar. 31, 2016	Mar. 31, 2015
REVENUE
Revenue	$ 0	$ 0	$ 0	$ 0
OPERATING EXPENSES
Administration expenses	775,216	504,724	2,620,324	980,637
Occupancy expenses	5,235	2,366	15,062	7,710
Research and development	510,301	9,475	806,578	15,797
TOTAL OPERATING EXPENSES	1,290,752	516,565	3,441,964	1,004,144
LOSS FROM OPERATIONS	(1,290,752)	(516,565)	(3,441,964)	(1,004,144)
OTHER INCOME (EXPENSE)
Interest expense	(1,104,315)	(199,287)	(2,678,604)	(847,942)
Interest income	0	13	2,027	16
Other expense	0	0	0	(50,002)
Change in fair value of derivative liabilities	57,118	(42,802)	(494,772)	79,940
Gain (loss) on debt settlements, net	0	331,457	(58,893)	366,341
Foreign currency transaction gain (loss)	186,070	(27,066)	47,366	(209,678)
TOTAL OTHER INCOME (EXPENSE)	(861,127)	62,315	(3,182,876)	(661,325)
LOSS BEFORE INCOME TAXES	(2,151,879)	(454,250)	(6,624,840)	(1,665,469)
INCOME TAX (EXPENSE) BENEFIT	(30)	0	71,970	79,302
NET INCOME (LOSS)	(2,151,909)	(454,250)	(6,552,870)	(1,586,167)
OTHER COMPREHENSIVE INCOME (LOSS)
Foreign currency translation gain (loss)	(238,292)	131,659	(126,413)	349,796
TOTAL OTHER COMPREHENSIVE INCOME (LOSS)	$ (2,390,201)	$ (322,591)	$ (6,679,283)	$ (1,236,371)
BASIC AND DILUTED NET LOSS PER SHARE ( in dollars per share)	$ 0	$ 0	$ (0.02)	$ (0.01)
BASIC AND DILUTED WEIGHTED AVERAGE SHARES OUTSTANDING (in shares)	510,808,665	201,772,426	419,957,374	124,223,579

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS	9 Months Ended
	Mar. 31, 2016USD ($)	Mar. 31, 2015USD ($)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (6,552,870)	$ (1,586,167)
Adjustments to Reconcile Net loss to Net Cash Used in Operating Activities:
Issuance and amortization of common stock for services	1,359,874	199,727
Issuance of preferred stock for services	0	1,067
(Gain) loss on settlement	58,893	(366,341)
Settlement fees paid in the form of debt	0	150,000
Foreign currency transaction loss (gain)	(47,366)	77,661
Depreciation expense	507	18
Amortization of debt discount	2,235,257	167,535
Change in fair value of derivative liabilities	494,772	(79,940)
Accretion of put premium	914,412	598,103
Changes in Assets and Liabilities:
GST receivable	(9,961)	(5,560)
Prepaid expenses and other assets	(246,311)	20,644
Accounts payable	(77,543)	5,322
Employee benefit liability	19,060	17,531
Accrued expenses	(326,341)	87,818
Accrued interest	(27,527)	15,041
NET CASH USED IN OPERATING ACTIVITIES	(2,205,144)	(697,541)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of equipment	(676)	(918)
NET CASH USED IN INVESTING ACTIVITIES	(676)	(918)
CASH FLOWS FROM FINANCING ACTIVITIES:
Loan repayments to directors and officer	(21,491)	(20,000)
Loan repayments	(23,843)	0
Proceeds from convertible promissory notes	4,177,500	675,500
Repayments of convertible promissory notes	(463,976)	0
Proceeds from issuance of common stock for cash	0	29,000
NET CASH PROVIDED BY FINANCING ACTIVITIES	3,668,190	684,500
Effect of exchange rate changes on cash	(90,971)	94,508
NET INCREASE (DECREASE) IN CASH	1,371,399	80,549
CASH AT BEGINNING OF PERIOD	107,627	87,799
CASH AT END OF PERIOD	1,479,026	168,348
Cash paid during the period:
Interest	0	0
Income Tax	0	0
Supplemental Disclosure of Non-Cash Investing and Financing Activities
Common stock issued for settlement of debt	0	152,285
Prepaid common stock issued for services	72,757	134,373
Reduction of put premium related to conversions of convertible note	1,034,454	37,032
Conversion of convertible notes and accrued interest to common stock	3,817,285	206,940
Discounts related to warrants issued with convertible debenture	1,666,635	0
Discounts related to lender costs	0	48,500
Discounts related to derivative liability	2,205,925	0
Conversion of loan payable to common stock	$ 0	$ 66,389

NATURE OF OPERATIONS AND SUMMAR

NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES	9 Months Ended
	Mar. 31, 2016
Accounting Policies [Abstract]
Nature Of Operations, Basis Of Presentation And Summary Of Significant Accounting And Reporting Policies [Text Block]	NOTE 1 – NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES Propanc PTY LTD was incorporated in Melbourne, Victoria Australia on October 15, 2007, and is based in Richmond, Victoria Australia. Since inception, substantially all of the efforts of the Company have been the development of new cancer treatments targeting high risk patients who need a follow up, nontoxic, long term therapy which prevents the cancer from returning and spreading. The Company anticipates establishing global markets for its technologies. On November 23, 2010, Propanc Health Group Corporation ("the Company", "we", "us", "our") was incorporated in the state of Delaware. In January 2011, to reorganize the Company, Propanc Health Group Corporation acquired all of the outstanding shares of Propanc PTY LTD on a one-for-one basis making it a wholly-owned subsidiary. The interim unaudited consolidated financial statements included herein have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”), and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of the Company’s management, all adjustments (consisting of normal recurring adjustments and reclassifications and non-recurring adjustments) necessary to present fairly our results of operations for the three and nine months ended March 31, 2016 and 2015 and cash flows for the nine months ended March 31, 2016 and 2015 and our financial position as of March 31, 2016 have been made. The results of operations for such interim periods are not necessarily indicative of the operating results to be expected for the full year. Certain information and disclosures normally included in the notes to the annual audited consolidated financial statements have been condensed or omitted from these interim unaudited consolidated financial statements. Accordingly, these interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the fiscal year ended June 30, 2015. The June 30, 2015 balance sheet is derived from those statements. The unaudited consolidated financial statements include the accounts of Propanc Health Group Corporation and its wholly-owned subsidiary, Propanc PTY LTD. All significant inter-company balances and transactions have been eliminated in consolidation. The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Significant estimates in the accompanying unaudited consolidated financial statements include the estimates of useful lives for depreciation, valuation of derivatives, valuation of beneficial conversion features on convertible debt, allowance for uncollectable receivables, valuation of equity based instruments issued for other than cash, the valuation allowance on deferred tax assets and foreign currency translation due to certain average exchange rates applied in lieu of spot rates on transaction dates. The Company’s functional currency is the Australian dollar (AUD). For financial reporting purposes, the Australian dollar has been translated into United States dollars ($) and/or USD as the reporting currency. Assets and liabilities are translated at the exchange rate in effect at the balance sheet date. Revenues and expenses are translated at the average rate of exchange prevailing during the reporting period. Equity transactions are translated at each historical transaction date spot rate. Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity (deficit) as “accumulated other comprehensive income (loss).” Gains and losses resulting from foreign currency transactions are included in the statements of operations and other comprehensive income (loss) as other income (expense). There have been no significant fluctuations in the exchange rate for the conversion of Australian dollars to USD after the balance sheet date. Other Comprehensive Income (Loss) for all periods presented, includes only foreign currency translation gains (losses). Foreign Beginning balance, June 30, 2015 $ 100,968 Foreign currency translation loss (126,413) Ending balance, March 31, 2016 $ (25,445) The Company measures their financial assets and liabilities in accordance with US GAAP. For certain of the Company’s financial instruments, including cash and cash equivalents, accounts and other receivables, accounts payable and accrued expenses and other liabilities, the carrying amounts approximate fair value due to their short maturities. Amounts recorded for loans payable, also approximate fair value because current interest rates available to us for debt with similar terms and maturities are substantially the same. The Company adopted accounting guidance for fair value measurements of financial assets and liabilities. The adoption did not have a material impact on the Company’s results of operations, financial position or liquidity. This standard defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). The guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels: Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. Level 3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us, which reflect those that a market participant would use. Cash and cash equivalents include cash on hand and at banks, short-term deposits with an original maturity of three months or less with financial institutions, and bank overdrafts. Bank overdrafts are reflected as a current liability on the balance sheets. There were no cash equivalents as of March 31, 2016 or June 30, 2015. Patent costs are stated at cost and reclassified to intangible assets and amortized on a straight-line basis over the estimated future periods if and once the patent has been granted by a regulatory agency, however, the Company will expense any costs as long as the Company is in the startup stage. Accordingly, as the Company's product was and is not currently approved for market, thus any patent costs incurred from 2013 through 2016 were expensed immediately. Currently, the Company has five international patents pending which was jointly applied for by the Company and another entity. For its lead patent, the Company received grant status, or has been accepted in South Africa, Australia, Japan and New Zealand. In addition, the United States Patent and Trademark Office or USPTO and European Patent Office or EPO have made preliminary indications that key features of the Company’s technology are patentable. The Company is presently working towards securing a patent in each region, covering as many aspects of its technology as possible, whilst also actively seeking protection throughout Eastern Europe, Asia and South America. Individual countries and regions where the Company is actively seeking protection for its lead patent include United States, Canada, Japan, Brazil, China, Mexico, Hong Kong, Singapore, Israel, Chile, Peru, Malaysia, Vietnam, Indonesia, Europe, Russia, India, and South Korea. The patent is now granted, or accepted in South Africa, Australia, and New Zealand. Of the four remaining patents, the Company has either filed an application, or is presently under examination in the country of origin. Two patents have been filed in the United States, one in Spain and another in Australia. Impairment of Long-Lived Assets In accordance with ASC 360-10, Long-lived assets, which include property and equipment and intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the assets. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. Revenues, expenses and balance sheet items are recognized net of the amount of GST except payable and receivable balances which are shown inclusive of GST. The GST incurred is payable on revenues to, and recoverable on purchases from, the Australian Taxation Office. Cash flows are presented in the statements of cash flow on a gross basis, except for the GST component of investing and financing activities, which are disclosed as operating cash flows. As of March 31, 2016 and June 30, 2015 the Company was owed $ 21,628 11,647 ASC Topic 815, Derivatives and Hedging The Company has entered into convertible notes, some of which contain variable conversion options, whereby the outstanding principal and accrued interest may be converted, by the holder, into common shares at a fixed discount to the price of the common stock at the time of conversion. The Company treats these convertible notes as stock settled debt under ASC 480 and measures the fair value of the notes at the time of issuance, which is the result of the share price discount at the time of conversion, and records the put premium as accretion to interest expense to the date of first conversion. The Company is governed by Australia and United States income tax laws, which are administered by the Australian Taxation Office and the United States Internal Revenue Service, respectively. The Company follows FASB ASC 740 when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities. The Company adopted provisions of ASC 740, Sections 25 through 60, “Accounting for Uncertainty in Income Taxes." These sections provide detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial statements. Tax positions must meet a “more-likely-than-not” recognition threshold at the effective date to be recognized upon the adoption of ASC 740 and in subsequent periods. In accordance with ASC 730-10, research and development costs are expensed when incurred. Total research and development costs for the nine months ended March 31, 2016 and 2015 were $ 806,578 15,797 The Company may apply for research and development tax concessions with the Australian Taxation Office on an annual basis. Although the amount is possible to estimate at year end, the Australian Taxation Office may reject or materially alter the claim amount. Accordingly, the Company does not recognize the benefit of the claim amount until cash receipt since collectability is not certain until such time. The tax concession is a refundable credit. If the Company has net income then the Company can receive the credit which reduces its income tax liability. If the Company has net losses then the Company may still receive a cash payment for the credit, however, the Company's net operating loss carryforwards are reduced by the gross equivalent loss that would produce the credit amount when the income tax rate is applied to that gross amount. The concession is recognized as an income tax benefit, in operations, upon receipt. The Company records stock based compensation in accordance with ASC section 718, “Stock Compensation” and Staff Accounting Bulletin (SAB) No. 107 (SAB 107) issued by the SEC in March 2005 regarding its interpretation of ASC 718. ASC 718 requires the fair value of all stock-based employee compensation awarded to employees to be recorded as an expense over the related requisite service period. The Company values any employee or non-employee stock based compensation at fair value using the Black-Scholes Option Pricing Model. The Company accounts for non-employee share-based awards in accordance with the measurement and recognition criteria of ASC 505-50 “Equity-Based Payments to Non-Employees”. In accordance with SEC Staff Accounting Bulletin (SAB) No. 104, Revenue Recognition Basic net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding for the period and, if dilutive, potential common shares outstanding during the period. Potentially dilutive securities consist of the incremental common shares issuable upon exercise of common stock equivalents such as stock options, warrants and convertible debt instruments. Potentially dilutive securities are excluded from the computation if their effect is anti-dilutive. As a result, the basic and diluted per share amounts for all periods presented are identical. For the nine months ended March 31, 2016, there were 37,569,634 520,153,814 Financial Accounting Standards Board, Accounting Standard Updates which are not effective until after March 31, 2016 are not expected to have a significant effect on the Company’s consolidated financial position or results of operations. The Company is evaluating or has implemented the following at March 31, 2016: In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements – Going Concern (Topic 205-40)”, which requires management to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern for each annual and interim reporting period. If substantial doubt exists, additional disclosure is required. This new standard will be effective for the Company for annual and interim periods beginning after December 15, 2016. Early adoption is permitted. The Company expects to adopt this new standard as of December 31, 2016. The Company does not expect this ASU to have a material impact on its consolidated financial statements. On May 8, 2015, the FASB issued ASU 2015-08, “Business Combinations (Topic 805) Pushdown Accounting In April 2015, the Financial Accounting Standards Board issued Accounting Standards Update No. 2015-03, "Simplifying the Presentation of Debt Issuance Costs,"

GOING CONCERN

GOING CONCERN	9 Months Ended
	Mar. 31, 2016
Accounting Policies [Abstract]
Going Concern [Text Block]	NOTE 2 – GOING CONCERN The accompanying unaudited consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. For the nine months ended March 31, 2016, the Company had no revenues and had a net loss of $ 6,552,870 2,205,144 3,526,238 3,520,873 27,518,541 The unaudited consolidated financial statements do not include any adjustments to reflect the possible future effect on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the outcome of this uncertainty. Successful completion of the Company’s development program and, ultimately, the attainment of profitable operations are dependent upon future events, including obtaining adequate financing to fulfill its development activities, acceptance of the Company's International patent application and achieving a level of sales adequate to support the Company’s cost structure. However, there can be no assurances that the Company will be able to secure additional equity investment or achieve an adequate sales level.

DUE TO DIRECTORS - RELATED PART

DUE TO DIRECTORS - RELATED PARTIES	9 Months Ended
	Mar. 31, 2016
Due to Related Parties [Abstract]
Due To Directors Related Party [Text Block]	NOTE 3 – DUE TO DIRECTORS - RELATED PARTIES Due to directors - related parties represents unsecured advances made by the directors for operating expenses on behalf of the Company such as intellectual property and formation expenses. The expenses were paid for on behalf of the Company are due upon demand. The Company is currently not being charged interest under these advances. The total amount owed these directors at March 31, 2016 and June 30, 2015 is $ 35,168 35,108

LOANS

LOANS	9 Months Ended
	Mar. 31, 2016
Receivables [Abstract]
Financing Receivables [Text Block]	NOTE 4 – LOANS Loans from Directors and Officer - Related Parties Loans from Directors and an Officer at March 31, 2016 and June 30, 2015 were $ 56,743 79,416 21,491 29,744 Other Loans from Unrelated Parties As of June 30, 2015, other loans from unrelated parties balance was $ 27,558 23,843 33,000 1,415 2,300

CONVERTIBLE NOTES

CONVERTIBLE NOTES	9 Months Ended
	Mar. 31, 2016
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	NOTE 5 – CONVERTIBLE NOTES Convertible notes and debenture $ 3,352,199 Unamortized discounts (2,770,210) Accrued interest 65,281 Premium 351,819 Convertible notes, net $ 999,089 On August 6, 2014 (execution date), the Company executed a convertible promissory note in the principal sum of $ 250,000 25,000 10 0 12 25,000 2,500 0.09 60 12 25,000 250,000 90,000 27,500 3,607 58,893 On February 10, 2015, the Company issued a convertible note payable for $ 45,000 7,500 8 February 10, 2016 The note is convertible at the option of the holder at any time after 180 days at a rate of 55% of the lowest trading bid price of the Company’s common stock for the ten prior trading days prior to the date upon which the conversion notice was received. 36,818 180 9,409 27,409 45,000 1,887 36,818 On February 17, 2015, the Company issued a second convertible note payable for $ 45,000 7,500 8 February 17, 2016 The note is convertible at the option of the holder at any time after 180 days at a rate of 55% of the lowest trading bid price of the Company’s common stock for the ten prior trading days prior to the date upon which the conversion notice was received. 36,818 180 9,409 27,409 45,000 2,229 36,818 On March 12, 2015, the Company issued a third convertible note payable for $ 170,500 13,000 8 March 12, 2016 55 139,500 170,500 8,580 139,500 On March 20, 2015, the Company issued a fourth convertible note payable for $ 150,000 8 55 122,727 150,000 9,436 122,727 In addition to each of the above initial convertible promissory notes (“initial convertible notes”), the Company issued to each lender another convertible promissory note for the same amounts of $ 45,000 45,000 170,500 150,000 55 In the event the Company redeems the initial convertible notes in full, the Company is required to pay off all principal, interest and any other amounts owing multiplied by i) 130 140 150 In the event of two specific defaults, which include the maintenance of a minimum trading price and an aggregate dollar trading volume of the Company's common shares, the holders may cancel the Back-End Notes and the related Notes Receivable and otherwise in the event of other defaults as defined in the securities purchase agreement, the amount of principal and accrued interest will become immediately due and payable and may be offset by amounts due to the Company by the holders. Additionally, the Back-End Notes will bear default interest at a rate of 24 On February 15, 2015, in connection with a six-month consulting agreement, the Company issued a convertible promissory note for $ 90,000 5 August 15, 2015 60 60,000 90,000 5,527 60,000 On March 12, 2015, the Company issued a convertible promissory note for $ 104,000 8 180 58 75,310 137,915 104,000 2,872 31,043 6,276 46,441 22,593 On March 12, 2015, in connection with a two-year consulting agreement, the Company issued a convertible promissory note for $ 60,000 10 0.0175 75 60,000 5,159 On April 20, 2015, the Company issued a convertible note payable for $ 17,500 8 55 14,318 16,500 803 13,500 79 On April 24, 2015, the Company received payment of the Note Receivable of $ 45,000 7,500 February 10, 2015 2,250 35,250 55 36,818 180 22,909 13,909 45,000 1,765 36,818 On April 24, 2015, the Company received payment of the Note Receivable of $ 45,000 7,500 February 17, 2015 2,250 35,250 55 36,818 180 22,909 13,909 1,000 46 818 3,308 On April 27, 2015, the Company received payment of the Note Receivable of $ 170,500 13,000 March 12, 2015 7,500 150,000 55 139,500 170,500 8,303 139,500 On May 19, 2015, the Company entered into a Securities Purchase Agreement (“SPA”), to issue a series of nine back end convertible notes in the principal sum of $ 782,500 37,500 37,500 157,500 150,000 17,500 37,500 37,500 157,500 150,000 55 782,500 The Back-End Notes may not be prepaid, except that if the initial convertible notes are redeemed by the Company within six months of their issuance, all obligations of the Company and holders under the Back-End Notes and the Notes Receivable will be deemed satisfied and such notes shall automatically be deemed cancelled and of no further force or effect. In the event of two specific defaults, which include the maintenance of a minimum trading price and an aggregate dollar trading volume of the Company's common shares, the holders may cancel the Back-End Notes and the related Notes Receivable and otherwise in the event of other defaults as defined in the securities purchase agreement, the amount of principal and accrued interest will become immediately due and payable and may be offset by amounts due to the Company by the holders. Additionally, the Back-End Notes will bear default interest at a rate of 24 Since the Back-End Notes are not convertible until the Notes Receivable are paid, and the Notes Receivable and Back-End Notes have a right of setoff, the Notes Receivable and Back-End Notes and related accrued interest receivable and payable have been netted for presentation purposes on the accompanying consolidated balance sheet. On June 2, 2015, the Company received payment of the Note Receivable of $ 150,000 7,500 142,500 55 122,727 125,000 8,849 102,273 2,329 On June 4, 2015 (execution date), the Company executed a convertible promissory note in the principal sum of $ 1,215,000 110,000 10 335,000 30,000 5,000 220,000 20,000 220,000 20,000 40 10 300,000 30,000 5,000 220,000 20,000 1,997 201,997 0.07 0.07 3,000,000 269,976 285,024 29,091 On July 14, 2015, the Company received payment of three Note Receivables of $ 352,500 17,690 334,810 288,409 288,409 287,500 15,184 235,227 3,558 On October 1, 2015, the Company received cash of $ 1,150,000 1,200,000 50,000 The Company issued the Promissory Note with a principal amount of $1,200,000 to the Lender. The Promissory Note has a maturity date of the earlier of: (i) the date on which the Company closes a subsequent equity offering in an amount greater than the principal amount of the Promissory Note; or (ii) June 24, 2016. On its face, the Promissory Note does not accrue any interest. In the event that the Lender does not proceed with a subsequent financing, beginning on the 46 th On October 14, 2015 and October 15, 2015, the Company received payment of six Note Receivables of $430,000, that offset the remaining six of the Back-End Notes that were issued on May 19, 2015. Proceeds from the Note Receivables of $22,265 were paid directly to legal fees resulting in net cash proceeds of $407,735 received by the Company. These Back-End Note are related to the initial convertible notes that was issued on May 19, 2015 and have the same terms as previously discussed. As a result, these Back-End Notes are now eligible for conversion at a rate of 55% of the lowest trading bid price of the Company’s common stock for the ten prior trading days including the date upon which the conversion notice was received. These convertible notes are treated as stock settled debt under ASC 480 and accordingly the Company is accreting a $351,818 put premium over 180 days from the execution of the convertible notes. During the nine months ended March 31, 2016, the Company has accreted $351,818 of the put premium resulting in the put premium being fully expensed. During the nine months ended March 31, 2016, the Company converted $ 135,000 4,702 110,455 11,213 On October 28, 2015 (the “Closing Date”), the Company entered into a securities purchase agreement dated as of the Closing Date (the “Purchase Agreement”) with a third party purchaser (the “Purchaser”). The Purchase Agreement provides that, upon the terms and subject to the conditions set forth therein, the Purchaser will invest $4,000,000 (“Investment Amount”) in exchange for a Convertible Debenture (the “Debenture”) in the principal amount of $ 4,400,000 26,190,476 0.001 0.60 4 On March 11, 2016, the Company entered into an Addendum (the “ Addendum ”) with the Purchaser pursuant to which the Company and the Purchaser agreed to new terms with respect to that certain securities purchase agreement entered into by and between the Company and the Purchaser dated as October 28, 2015. Addendum Under the Addendum, the Company and the Purchaser agreed that the balance of the deposit control account, after giving effect to the amounts released from such account as of the date of the Addendum, will be released to the Company in two installments as follows: (1) up to $ 1,200,000 375,000 The Company and the Purchaser agreed that the new conversion price will be $ 0.03 22.5 Under the Addendum, the Purchaser agreed to limit the number of shares of common stock it sells on any trading day to an amount of shares that is less than 25 The Company also agreed to reserve an additional 300,000,000 The Company and the Purchaser agreed that the October Financing Documents, as applicable, will continue in effect and remain in place, except to the extent modified by the Addendum. Securities Purchase Agreement and Debenture Under the terms of the Purchase Agreement, the Purchaser agreed to deliver the Promissory Note entered into by the Company and Purchaser on September 24, 2015 with a principal amount of $1,200,000 (the “Prior Note”) (as noted above). The parties further agreed that the Prior Note was deemed cancelled upon the delivery by the Purchaser to the Company and the amount of the Prior Note is included in the Investment Amount under the Purchase Agreement. Under the terms of the Purchase Agreement and Debenture, $ 2,800,000 25,000 25,000 50,000 4,350,000 The Purchase Agreement contains customary representations, warranties and covenants by, among and for the benefit of the parties. The Company also agreed to pay up to $ 50,000 The Debenture has a 10 5 payable quarterly in cash (or if certain conditions are met, in stock at the Company’s option) on January 1, April 1, July 1 and October 1. The Debenture was, prior to Addendum, convertible at any time, in whole or in part, at the Purchaser’s option into shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a conversion price equal to $0.042, which is the volume weighted average price of the Company’s Common Stock five days prior to the execution of the Debenture (subject to adjustment) (the “Conversion Price”). At any time after the effective date of the registration statement, the Purchaser has the opportunity to convert up to an aggregate of $2,090,000 of the Debenture, at one or more conversion dates, into shares of Common Stock at a conversion price equal to the VWAP of the Common Stock over the five (5) trading days prior to such Effective Date. The Purchaser option to convert at such a conversion price expires when the Purchaser converts an aggregate of $2,090,000 of the Debenture using such conversion price. If the volume weighted average price of the Company Common Stock on any trading day is less than the Conversion Price, the Purchaser may convert at a price per share equal to a twenty percent (20%) discount to the average of the two lowest closing prices during the five trading days prior to the date of conversion. At no time will the Purchaser be entitled to convert any portion of the Debenture to the extent that after such conversion, the Purchaser (together with its affiliates) would beneficially own more than 4.99% of the outstanding shares of Common Stock as of such date. During the nine months ended March 31, 2016, the Company withdrew a principal amount of $2,425,000 from the deposit control account, of which $269,976 was paid directly as partial payment of a note dated June 4, 2015 and $33,437 were paid directly to legal fees resulting in net cash proceeds of $2,121,587 received by the Company. An aggregate total of $3,290,000 of these notes were bifurcated with the embedded conversion option recorded as a derivative liability at fair value (See Note 10). During the nine months ended March 31, 2016, the Company converted $1,065,301 of principal into shares of the Company’s common stock (See Note 6). Accrued interest as of March 31, 2016 was $44,794. The Debenture includes customary event of default provisions, and provides for a default interest rate of 18 Subject to the conditions set forth in the Debenture, the Company has the right at any time to redeem some or all of the total outstanding amount then remaining under the Debenture in cash at a price equal to 125% of the total amount of the Debenture outstanding on the twentieth (20th) trading date following the date the Company delivers notice of such redemption to the Purchaser. The Warrants are exercisable in whole or in part, at an initial exercise price per share of $ 0.60 In connection with the execution of the Purchase Agreement, on the Closing Date, the Company and the Purchaser also entered into a registration rights agreement dated as of the Closing Date (the “Registration Rights Agreement”). Pursuant to the Registration Rights Agreement, the Company has agreed to file an initial registration statement (“Registration Statement”) with the SEC to register the resale of the Common Stock into which the Debenture may be converted or the Warrant may be exercised, within 30 days following the Closing Date. The Registration Statement must also be declared effective by the 100th calendar day after the Closing Date, subject to a 20-day extension as requested by the Company and consented to by the Purchaser. On November 23, 2015, the Company filed a registration statement with the SEC and on December 10, 2015, the registration statement was deemed effective. If at any time all of the shares of Common Stock underlying the Debenture or the Warrant are not covered by the initial Registration Statement, the Company has agreed to file with the SEC one or more additional Registration Statements so as to cover all of the shares of Common Stock underlying the Debenture or the Warrant not covered by such initial Registration Statement, in each case, as soon as practicable, but in no event later than the applicable filing deadline for such additional Registration Statements as provided in the Registration Rights Agreement. In connection with the Purchase Agreement, the Company entered into a Security Agreement dated as of even date therewith with the Purchaser whereby the Company agreed to grant to Purchaser an unconditional and continuing, first priority security interest in all of the assets and property of the Company to secure the prompt payment, performance and discharge in full of all of Company’s obligations under the Debentures, Warrants and the other transaction documents until ten days following the such time as the Registration Statement is declared effective by the SEC and the equity conditions set forth in the Debenture are met. The Company recorded $ 4,207,500 166,500 1,852,757 43,773

STOCKHOLDERS' DEFICIT

STOCKHOLDERS' DEFICIT	9 Months Ended
	Mar. 31, 2016
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	NOTE 6 – STOCKHOLDERS’ DEFICIT Preferred Stock: The total number of preferred shares authorized and that may be issued by the Company is 10,000,000 0.01 Of the total preferred shares authorized, pursuant to Certificate of Designation filed on December 9, 2014, 500,000 0.01 500,000 0.00213 1,067 8,161,000 Of the total preferred shares authorized, pursuant to Certificate of Designation filed on June 16, 2015, up to five (5) shares have been designated as Series B preferred stock, with a par value of $ 0.01 1 0.1165 0.12 Common Stock: On November 12, 2014, the Company filed an amendment to the Company’s Certificate of Incorporation with the Secretary of State of the State of Delaware, to increase the Company’s authorized common stock from one hundred million (100,000,000) 0.001 (10,000,000,000) 0.001 (10,000,000,000) 0.001 (2,000,000,000) 0.001 Shares issued for services On June 4, 2015, the Company entered into an agreement with a consultant to provide services over a six month period in exchange for 500,000 500,000 0.0706 35,300 500,000 30,285 On August 26, 2015, the Company issued 560,000 560,000 0.04 22,400 On September 8, 2015, the Company issued 600,000 600,000 0.0369 22,140 On July 24, 2015, the Company entered into an agreement with a consultant to provide services over a six month period. The Company agreed to issue the consultant 8,000,000 8,000,000 0.0435 348,000 8,000,000 348,000 to this agreement. On October 1, 2015, the Company entered into an agreement with a consultant to provide services over a one year period. The Company agreed to issue the consultant 1,500,000 1,500,000 1,500,000 0.031 46,500 23,314 1,100,000 400,000 In February 2016, the Company terminated this agreement. On October 16, 2015, the Company issued 4,000,000 4,000,000 0.0415 166,000 151,486 On December 30, 2015, the Company entered into an agreement with a consultant to provide services over a nine month period. The Company agreed to issue the consultant 1,000,000 1,000,000 0.0260 26,000 1,000,000 8,730 On December 30, 2015, the Company entered into an agreement, effective on January 1, 2016, with a consultant to provide services over a six month period. The Company agreed to issue the consultant 2,250,000 2,250,000 0.0279 62,775 375,000 20,925 On December 31, 2015, the Company entered into an agreement, effective on January 1, 2016, with a law firm to provide legal services. The Company agreed to issue the law firm 1,600,000 1,600,000 0.0279 44,640 1,600,000 On November 11, 2015, the Company entered into an agreement with a consultant to provide services over a six month period. The Company agreed to issue the consultant 2,000,000 2,000,000 0.0157 31,400 2,000,000 24,326 Shares issued for conversion of convertible debt On August 14, 2015, pursuant to a conversion notice, $ 20,500 0.02365 866,796 On August 14, 2015, pursuant to a conversion notice, $ 20,802 0.02365 879,585 On August 26, 2015, pursuant to a conversion notice, $ 26,068 0.018425 1,414,843 On September 1, 2015, pursuant to a conversion notice, $ 25,723 0.018425 1,396,108 On September 4, 2015, pursuant to a conversion notice, $ 15,648 0.018425 849,263 On September 16, 2015, pursuant to a conversion notice, $ 15,687 0.018975 826,726 On September 18, 2015, pursuant to a conversion notice, $ 15,694 0.017875 877,969 On September 22, 2015, pursuant to a conversion notice, $ 15,638 0.01716 911,294 On October 1, 2015, pursuant to a conversion notice, $ 26,635 0.012375 2,152,289 On October 7, 2015, pursuant to a conversion notice, $ 31,374 0.012375 2,535,293 On October 13, 2015, pursuant to a conversion notice, $ 109,004 0.012375 8,808,435 On October 13, 2015, pursuant to a conversion notice, $ 104,712 0.012375 8,461,602 On October 15, 2015, pursuant to a conversion notice, $ 50,000 0.01 5,000,000 On November 17, 2015, pursuant to a conversion notice, $ 2,099 0.01986 105,709 On November 17, 2015, pursuant to a conversion notice, $ 35,000 0.01 3,500,000 On November 23, 2015, pursuant to a conversion notice, $ 15,707 0.0154 1,019,925 On November 24, 2015, pursuant to a conversion notice, $ 20,947 0.0154 1,360,185 On November 30, 2015, pursuant to a conversion notice, $ 49,287 0.0154 3,200,448 On December 4, 2015, pursuant to a conversion notice, $ 31,703 0.0154 2,058,637 On December 8, 2015, pursuant to a conversion notice, $ 63,213 0.01595 3,963,207 On December 11, 2015, pursuant to a conversion notice, $ 50,000 0.02608 1,917,178 On December 15, 2015, pursuant to a conversion notice, $ 50,000 0.02712 1,843,658 On December 16, 2015, pursuant to a conversion notice, $ 31,782 0.01650 1,926,177 On December 17, 2015, pursuant to a conversion notice, $ 40,000 0.02500 1,600,000 On December 21, 2015, pursuant to a conversion notice, $ 40,000 0.02360 1,694,916 On December 21, 2015, pursuant to a conversion notice, $ 51,719 0.01584 3,265,069 On December 23, 2015, pursuant to a conversion notice, $ 40,000 0.02320 1,724,138 On December 23, 2015, pursuant to a conversion notice, $ 31,414 0.01584 1,983,188 On December 28, 2015, pursuant to a conversion notice, $ 40,000 0.02320 1,724,138 On December 29, 2015, pursuant to a conversion notice, $ 15,727 0.01573 999,783 On December 30, 2015, pursuant to a conversion notice, $ 40,000 0.02284 1,751,314 On January 4, 2016, pursuant to a conversion notice, $ 20,995 0.0143 1,468,187 On January 4, 2016, pursuant to a conversion notice, $ 54,375 0.02156 2,522,032 On January 6, 2016, pursuant to a conversion notice, $ 40,000 0.02068 1,934,236 On January 6, 2016, pursuant to a conversion notice, $ 21,004 0.014135 1,485,946 On January 8, 2016, pursuant to a conversion notice, $ 40,000 0.02008 1,992,032 On January 8, 2016, pursuant to a conversion notice, $ 10,506 0.0113805 761,050 On January 11, 2016, pursuant to a conversion notice, $ 10,513 0.01375 764,573 On January 12, 2016, pursuant to a conversion notice, $ 10,515 0.012705 827,632 On January 13, 2016, pursuant to a conversion notice, $ 17,650 0.01864 946,889 On January 13, 2016, pursuant to a conversion notice, $ 10,517 0.011825 889,409 On January 13, 2016, pursuant to a conversion notice, $ 20,820 0.01056 1,971,565 On January 14, 2016, pursuant to a conversion notice, $ 82,350 0.0168 4,901,786 On January 19, 2016, pursuant to a conversion notice, $ 10,423 0.009955 1,047,013 On January 20, 2016, pursuant to a conversion notice, $ 5,108 0.009955 513,158 On January 21, 2016, pursuant to a conversion notice, $ 25,000 0.01488 1,680,108 On January 21, 2016, pursuant to a conversion notice, $ 12,513 0.009955 1,256,944 On January 25, 2016, pursuant to a conversion notice, $ 25,000 0.01492 1,675,604 On January 25, 2016, pursuant to a conversion notice, $ 13,567 0.009955 1,362,834 On January 25, 2016, pursuant to a conversion notice, $ 65,159 0.0150 4,343,934 On January 27, 2016, pursuant to a conversion notice, $ 15,661 0.009955 1,573,161 On January 29, 2016, pursuant to a conversion notice, $ 25,000 0.015080 1,657,825 On February 1, 2016, pursuant to a conversion notice, $ 16,722 0.009955 1,679,800 On February 3, 2016, pursuant to a conversion notice, $ 20,000 0.0148 1,351,352 On February 3, 2016, pursuant to a conversion notice, $ 10,456 0.009405 1,111,737 On February 4, 2016, pursuant to a conversion notice, $ 25,000 0.0142 1,760,564 On February 4, 2016, pursuant to a conversion notice, $ 26,145 0.009405 2,779,927 On February 8, 2016, pursuant to a conversion notice, $ 15,700 0.009405 1,669,354 On February 9, 2016, pursuant to a conversion notice, $ 198,140 principal was converted at $ 0.0100 19,814,000 On February 9, 2016, pursuant to a conversion notice, $ 25,000 0.0138 1,811,595 On February 10, 2016, pursuant to a conversion notice, $ 12,042 0.00864 1,394,548 On February 12, 2016, pursuant to a conversion notice, $ 40,000 0.01268 3,154,575 On February 16, 2016, pursuant to a conversion notice, $ 10,276 0.00864 1,221,172 On February 17, 2016, pursuant to a conversion notice, $ 10,278 0.00787 1,306,848 On February 22, 2016, pursuant to a conversion notice, $ 20,579 0.00787 2,616,482 On February 23, 2016, pursuant to a conversion notice, $ 30,000 0.01184 2,533,784 On February 25, 2016, pursuant to a conversion notice, $ 115,975 0.0100 11,597,463 On February 25, 2016, pursuant to a conversion notice, $ 30,000 0.0100 3,000,000 On February 26, 2016, pursuant to a conversion notice, $ 30,000 0.0096 3,275,110 On March 2, 2016, pursuant to a conversion notice, $ 25,773 0.00567 4,549,444 On March 4, 2016, pursuant to a conversion notice, $ 50,000 0.00832 6,009,616 On March 8, 2016, pursuant to a conversion notice, $ 143,000 0.00868 16,474,655 On March 13, 2016, pursuant to a conversion notice, $ 8,274 0.00201 4,107,483 On March 15, 2016, pursuant to a conversion notice, $ 126,549 0.00572 22,123,958 On March 18, 2016, pursuant to a conversion notice, $ 67,237 0.00660 10,187,380 On March 29, 2016, pursuant to a conversion notice, $ 62,926 0.01920 3,277,403 Warrants: On October 28, 2015, pursuant to a convertible debenture, the Company issued 26,190,476 0.60 4 In connection with above agreement dated November 11, 2015, on February 22, 2016, the Company issued to the consultant, 4,000,000 0.0119 0.045 314 60 1.54 47,560 10,714 36,846 As of March 31, 2016, there were 37,569,634

COMMITMENTS AND CONTINGIENCIES

COMMITMENTS AND CONTINGIENCIES	9 Months Ended
	Mar. 31, 2016
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	NOTE 7 – COMMITMENTS AND CONTINGIENCIES Legal Matters From time to time, the Company may be involved in litigation relating to claims arising out of the Company’s operations in the normal course of business. The Company is presently in litigation with Typenex Co-Investment, LLC, a Utah limited liability company (“Typenex”), in private arbitration in the State of Utah. In connection with this arbitration, a lawsuit is also pending in the Third Judicial District Court of Salt Lake County, Utah, which has been stayed pending the outcome of the arbitration. Typenex is claiming funds due under a convertible promissory note dated June 4, 2015. The Company is actively defending all allegations made by Typenex, and has lodged a counter claim against the plaintiff in the arbitration. The Company does not believe the result of this litigation matter will have a material adverse effect on our financial conditions or results of operations. The Company negotiated a settlement with JMJ Financial Inc., a Florida corporation (“JMJ”), and on December 10, 2015, the Company repaid cash of $ 90,000 Operating Agreements In November 2009, the Company entered into a commercialization agreement whereby the Company agreed to pay royalties of 2 5 Operating Leases On May 1, 2015, the Company moved to new premises. On May 1, 2015, the Company entered into a month to month lease agreement with new landlord with a monthly rental fee of approximately $ 2,200 On May 5, 2016, the Company entered into a month to month lease agreement with a new landlord with a monthly rental fee of approximately $ 3,000 Rent expense for the nine months ended March 31, 2016 and 2015 was $ 15,062 7,710

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Mar. 31, 2016
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	NOTE 8 – RELATED PARTY TRANSACTIONS Since inception, Propanc Health Group Corporation has conducted transactions with directors and director related entities. These transactions included the following: As of March 31, 2016 and June 30, 2015, the Company owed certain directors a total of $ 56,743 79,416 As of March 31, 2016 and June 30 2015, the Company owed two directors a total of $ 35,168 35,108

CONCENTRATIONS AND RISKS

CONCENTRATIONS AND RISKS	9 Months Ended
	Mar. 31, 2016
Risks and Uncertainties [Abstract]
Concentration Risk Disclosure [Text Block]	NOTE 9 – CONCENTRATIONS AND RISKS Concentration of Credit Risk The Company maintains its cash in banks and financial institutions in Australia. Bank deposits in Australian banks are uninsured. The Company has not experienced any losses in such accounts through March 31, 2016. Receivable Concentration As of March 31, 2016 and June 30, 2015, the Company’s receivables were 100 Product and Patent Concentration As of March 31, 2016, the Company was undertaking preclinical activities for their lead product. The Company was also undertaking research to uncover the mechanism of action of their lead product in order to screen new compounds for development. The Company previously expanded by the filing of an international PCT patent application (No. PCT/AU2010/001403) directed to enhanced proenzyme formulations and combination therapies. The international PCT application has been based on previous provisional patent applications capturing the Company’s ongoing research and development in this area. The Company received grant status in South Africa and more recently in Australia and Japan New Zealand. In addition, the United States Patent and Trademark Office or USPTO and European Patent Office or EPO have made preliminary indications that key features of our technology are patentable. The Company is presently working towards securing a patent in each region, covering as many aspects of its technology as possible, while also actively seeking protection throughout Eastern Europe, Asia and South America. Individual countries and regions, include United States, Canada, Japan, Brazil, China, Mexico, Hong Kong, Singapore, Israel, Chile, Peru, Malaysia, Vietnam, Indonesia, Europe, Russia, India, and South Korea. The patent is granted in South Africa, Australia, and New Zealand. Further provisional patent filings are also expected to be filed to capture and protect additional patentable subject matter that is identified, namely further enhanced formulations, combination treatments, use of recombinant products, modes of action and molecular targets. Foreign Operations As of March 31, 2016 and June 30, 2015, the Company's operations are based in Australia.

DERIVATIVE FINANCIAL INSTRUMENT

DERIVATIVE FINANCIAL INSTRUMENTS and FAIR VALUE MEASUREMENTS	9 Months Ended
	Mar. 31, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging Activities Disclosure [Text Block]	NOTE 10 - DERIVATIVE FINANCIAL INSTRUMENTS and FAIR VALUE MEASUREMENTS Derivative Financial Instruments: The Company applies the provisions of ASC Topic 815-40, Contracts in Entity’s Own Equity 3,000,000 2,922,199 The Company calculates the estimated fair values of the liabilities for derivative instruments using the Black Scholes (“BSM”) option pricing model. The closing price of the Company’s common stock at March 31, 2016 was $ 0.0304 March 31, 2016 Volatility 217 % Expected remaining term 2.50 Risk-free interest rate 1.31 % Expected dividend yield none Convertible Debt Initial Valuations March 31, Volatility 217 % 217 % Expected Remaining Term 0.70 0.58 Risk Free Interest Rate 0.7 % 0.6 % Expected dividend yield none none Fair Value Measurements: The Company measures and reports at fair value the liability for derivative instruments. The fair value liabilities for price adjustable warrants and embedded conversion options have been recorded as determined utilizing the BSM option pricing model. Balance at Quoted Prices Significant March in Active Other Significant 31, Markets for Observable Unobservable 2016 Identical Assets Inputs Inputs (Level 1) (Level 2) (Level 3) Embedded conversion option liabilities $ 3,659,506 $ — $ — $ 3,659,506 Fair value of liability for warrant derivative instruments $ 80,630 $ — $ — $ 80,630 Total $ 3,740,136 $ — $ — $ 3,740,136 Fair Value of Liability for Derivative Instruments Balance at June 30, 2015 $ 1,049,929 Effects of foreign currency exchange rate changes (10,490) Initial fair value of embedded conversion option derivative liability recorded as debt discount 2,205,925 Initial fair value of embedded conversion option derivative liability recorded as change in fair value of ECO 2,211,529 Change in fair value included in statements of operations (1,716,757) Balance at March 31, 2016 $ 3,740,136

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Mar. 31, 2016
Subsequent Events [Abstract]
Subsequent Events [Text Block]	NOTE 11 – SUBSEQUENT EVENTS Shares issued for conversion of convertible debt On April 1, 2016, pursuant to a conversion notice, $ 54,375 0.01705 3,189,150 On April 4, 2016, pursuant to a conversion notice, $ 75,000 0.01705 4,398,827 On April 5, 2016, pursuant to a conversion notice, $ 70,000 0.01705 4,105,572 On April 7, 2016, pursuant to a conversion notice, $ 75,000 0.01705 4,398,827 On April 12, 2016, pursuant to a conversion notice, $ 75,000 0.019375 3,870,968 On April 18, 2016, pursuant to a conversion notice, $ 75,000 0.0194525 3,855,546 On April 19, 2016, pursuant to a conversion notice, $ 75,000 0.0194525 3,855,546 On April 20, 2016, pursuant to a conversion notice, $ 29,218 0.01419 2,059,042 On April 21, 2016, pursuant to a conversion notice, $ 75,000 0.01984 3,780,242 On April 21, 2016, pursuant to a conversion notice, $ 15,628 0.01419 1,101,335 On April 22, 2016, pursuant to a conversion notice, $ 48,610 0.01419 3,425,642 On April 22, 2016, pursuant to a conversion notice, $ 150,000 0.01984 7,560,484 On April 26, 2016, pursuant to a conversion notice, $ 150,000 0.01984 7,560,484 On April 27, 2016, pursuant to a conversion notice, $ 156,477 0.01463 10,695,606 On April 27, 2016, pursuant to a conversion notice, $ 634,880 0.01984 32,000,000 On April 27, 2016, pursuant to a conversion notice, $ 26,868 0.01463 1,836,534 On May 2, 2016, pursuant to a conversion notice, $ 325,000 0.020925 15,531,661 Shares issued for services On April 14, 2016 (“Grant Date”), the Board of Directors of the Company, through unanimous written consent, granted 71,500,000 71,500,000 0.03 23,833,333 23,833,333 23,833,334 On April 14, 2016, the Board of Director of the Company, through unanimous written consent approved Amendment No.1 to the Nathanielsz Employment Agreement to include a provision in the Nathanielsz Employment Agreement pursuant to which the Company will pay Mr. Nathanielsz a monthly amount to cover the costs relating to Mr. Nathanielsz use of a vehicle. On April 14, 2016, the Board of Director of the Company, through unanimous written consent approved the payment of an annual bonus to the Company’s CEO based on certain performance achievements in 2015 in accordance with the terms of the Nathanielsz Employment Agreement. The bonus amount approved was $200,000 AUD (or 66.66% of the CEO’s current base salary). On April 22, 2016, the Company entered into an agreement with a consultant to provide services over a one year period. The Company agreed to issue the consultant 6,250,000 shares of common stock. The Company valued the 6,250,000 shares based on the market price on the effective date of the agreement of $0.03 and will amortize the $187,500 over the one year term of the agreement. The Company also agreed to issue the consultant an additional total of 3,750,000 shares of common stock upon completion of certain services. On April 30, 2016, the Company issued 6,250,000 shares of common stock related to this agreement.

NATURE OF OPERATIONS AND SUMM17

NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Policies)	9 Months Ended
	Mar. 31, 2016
Accounting Policies [Abstract]
Nature of Operations, Policy [Policy Text Block]	Nature of Operations Propanc PTY LTD was incorporated in Melbourne, Victoria Australia on October 15, 2007, and is based in Richmond, Victoria Australia. Since inception, substantially all of the efforts of the Company have been the development of new cancer treatments targeting high risk patients who need a follow up, nontoxic, long term therapy which prevents the cancer from returning and spreading. The Company anticipates establishing global markets for its technologies. On November 23, 2010, Propanc Health Group Corporation ("the Company", "we", "us", "our") was incorporated in the state of Delaware. In January 2011, to reorganize the Company, Propanc Health Group Corporation acquired all of the outstanding shares of Propanc PTY LTD on a one-for-one basis making it a wholly-owned subsidiary.
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The interim unaudited consolidated financial statements included herein have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”), and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of the Company’s management, all adjustments (consisting of normal recurring adjustments and reclassifications and non-recurring adjustments) necessary to present fairly our results of operations for the three and nine months ended March 31, 2016 and 2015 and cash flows for the nine months ended March 31, 2016 and 2015 and our financial position as of March 31, 2016 have been made. The results of operations for such interim periods are not necessarily indicative of the operating results to be expected for the full year. Certain information and disclosures normally included in the notes to the annual audited consolidated financial statements have been condensed or omitted from these interim unaudited consolidated financial statements. Accordingly, these interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the fiscal year ended June 30, 2015. The June 30, 2015 balance sheet is derived from those statements.
Consolidation, Policy [Policy Text Block]	Principals of Consolidation The unaudited consolidated financial statements include the accounts of Propanc Health Group Corporation and its wholly-owned subsidiary, Propanc PTY LTD. All significant inter-company balances and transactions have been eliminated in consolidation.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Significant estimates in the accompanying unaudited consolidated financial statements include the estimates of useful lives for depreciation, valuation of derivatives, valuation of beneficial conversion features on convertible debt, allowance for uncollectable receivables, valuation of equity based instruments issued for other than cash, the valuation allowance on deferred tax assets and foreign currency translation due to certain average exchange rates applied in lieu of spot rates on transaction dates.
Foreign Currency Transactions and Translations Policy [Policy Text Block]	Foreign Currency Translation and Other Comprehensive Income (Loss) The Company’s functional currency is the Australian dollar (AUD). For financial reporting purposes, the Australian dollar has been translated into United States dollars ($) and/or USD as the reporting currency. Assets and liabilities are translated at the exchange rate in effect at the balance sheet date. Revenues and expenses are translated at the average rate of exchange prevailing during the reporting period. Equity transactions are translated at each historical transaction date spot rate. Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity (deficit) as “accumulated other comprehensive income (loss).” Gains and losses resulting from foreign currency transactions are included in the statements of operations and other comprehensive income (loss) as other income (expense). There have been no significant fluctuations in the exchange rate for the conversion of Australian dollars to USD after the balance sheet date. Other Comprehensive Income (Loss) for all periods presented, includes only foreign currency translation gains (losses). Foreign Beginning balance, June 30, 2015 $ 100,968 Foreign currency translation loss (126,413) Ending balance, March 31, 2016 $ (25,445)
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair Value of Financial Instruments and Fair Value Measurements The Company measures their financial assets and liabilities in accordance with US GAAP. For certain of the Company’s financial instruments, including cash and cash equivalents, accounts and other receivables, accounts payable and accrued expenses and other liabilities, the carrying amounts approximate fair value due to their short maturities. Amounts recorded for loans payable, also approximate fair value because current interest rates available to us for debt with similar terms and maturities are substantially the same. The Company adopted accounting guidance for fair value measurements of financial assets and liabilities. The adoption did not have a material impact on the Company’s results of operations, financial position or liquidity. This standard defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). The guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels: Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. Level 3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us, which reflect those that a market participant would use.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and cash equivalents include cash on hand and at banks, short-term deposits with an original maturity of three months or less with financial institutions, and bank overdrafts. Bank overdrafts are reflected as a current liability on the balance sheets. There were no cash equivalents as of March 31, 2016 or June 30, 2015.
Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]	Patent costs are stated at cost and reclassified to intangible assets and amortized on a straight-line basis over the estimated future periods if and once the patent has been granted by a regulatory agency, however, the Company will expense any costs as long as the Company is in the startup stage. Accordingly, as the Company's product was and is not currently approved for market, thus any patent costs incurred from 2013 through 2016 were expensed immediately. Currently, the Company has five international patents pending which was jointly applied for by the Company and another entity. For its lead patent, the Company received grant status, or has been accepted in South Africa, Australia, Japan and New Zealand. In addition, the United States Patent and Trademark Office or USPTO and European Patent Office or EPO have made preliminary indications that key features of the Company’s technology are patentable. The Company is presently working towards securing a patent in each region, covering as many aspects of its technology as possible, whilst also actively seeking protection throughout Eastern Europe, Asia and South America. Individual countries and regions where the Company is actively seeking protection for its lead patent include United States, Canada, Japan, Brazil, China, Mexico, Hong Kong, Singapore, Israel, Chile, Peru, Malaysia, Vietnam, Indonesia, Europe, Russia, India, and South Korea. The patent is now granted, or accepted in South Africa, Australia, and New Zealand. Of the four remaining patents, the Company has either filed an application, or is presently under examination in the country of origin. Two patents have been filed in the United States, one in Spain and another in Australia.
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	Impairment of Long-Lived Assets In accordance with ASC 360-10, Long-lived assets, which include property and equipment and intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the assets. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable.
Goods And Service Tax [Policy Text Block]	Australian Goods and Services Tax (GST) Revenues, expenses and balance sheet items are recognized net of the amount of GST except payable and receivable balances which are shown inclusive of GST. The GST incurred is payable on revenues to, and recoverable on purchases from, the Australian Taxation Office. Cash flows are presented in the statements of cash flow on a gross basis, except for the GST component of investing and financing activities, which are disclosed as operating cash flows. As of March 31, 2016 and June 30, 2015 the Company was owed $ 21,628 11,647
Derivatives, Policy [Policy Text Block]	Derivative Instruments ASC Topic 815, Derivatives and Hedging
Convertible Notes [Policy Text Block]	Convertible Notes With Variable Conversion Options The Company has entered into convertible notes, some of which contain variable conversion options, whereby the outstanding principal and accrued interest may be converted, by the holder, into common shares at a fixed discount to the price of the common stock at the time of conversion. The Company treats these convertible notes as stock settled debt under ASC 480 and measures the fair value of the notes at the time of issuance, which is the result of the share price discount at the time of conversion, and records the put premium as accretion to interest expense to the date of first conversion.
Income Tax, Policy [Policy Text Block]	Income Taxes The Company is governed by Australia and United States income tax laws, which are administered by the Australian Taxation Office and the United States Internal Revenue Service, respectively. The Company follows FASB ASC 740 when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities. The Company adopted provisions of ASC 740, Sections 25 through 60, “Accounting for Uncertainty in Income Taxes." These sections provide detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial statements. Tax positions must meet a “more-likely-than-not” recognition threshold at the effective date to be recognized upon the adoption of ASC 740 and in subsequent periods.
Research and Development Expense, Policy [Policy Text Block]	Research and Development Costs and Tax Credits In accordance with ASC 730-10, research and development costs are expensed when incurred. Total research and development costs for the nine months ended March 31, 2016 and 2015 were $ 806,578 15,797 The Company may apply for research and development tax concessions with the Australian Taxation Office on an annual basis. Although the amount is possible to estimate at year end, the Australian Taxation Office may reject or materially alter the claim amount. Accordingly, the Company does not recognize the benefit of the claim amount until cash receipt since collectability is not certain until such time. The tax concession is a refundable credit. If the Company has net income then the Company can receive the credit which reduces its income tax liability. If the Company has net losses then the Company may still receive a cash payment for the credit, however, the Company's net operating loss carryforwards are reduced by the gross equivalent loss that would produce the credit amount when the income tax rate is applied to that gross amount. The concession is recognized as an income tax benefit, in operations, upon receipt.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock Based Compensation The Company records stock based compensation in accordance with ASC section 718, “Stock Compensation” and Staff Accounting Bulletin (SAB) No. 107 (SAB 107) issued by the SEC in March 2005 regarding its interpretation of ASC 718. ASC 718 requires the fair value of all stock-based employee compensation awarded to employees to be recorded as an expense over the related requisite service period. The Company values any employee or non-employee stock based compensation at fair value using the Black-Scholes Option Pricing Model. The Company accounts for non-employee share-based awards in accordance with the measurement and recognition criteria of ASC 505-50 “Equity-Based Payments to Non-Employees”.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition In accordance with SEC Staff Accounting Bulletin (SAB) No. 104, Revenue Recognition
Earnings Per Share, Policy [Policy Text Block]	Basic and Diluted Net Loss Per Common Share Basic net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding for the period and, if dilutive, potential common shares outstanding during the period. Potentially dilutive securities consist of the incremental common shares issuable upon exercise of common stock equivalents such as stock options, warrants and convertible debt instruments. Potentially dilutive securities are excluded from the computation if their effect is anti-dilutive. As a result, the basic and diluted per share amounts for all periods presented are identical. For the nine months ended March 31, 2016, there were 37,569,634 520,153,814
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Adopted Accounting Pronouncements Financial Accounting Standards Board, Accounting Standard Updates which are not effective until after March 31, 2016 are not expected to have a significant effect on the Company’s consolidated financial position or results of operations. The Company is evaluating or has implemented the following at March 31, 2016: In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements – Going Concern (Topic 205-40)”, which requires management to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern for each annual and interim reporting period. If substantial doubt exists, additional disclosure is required. This new standard will be effective for the Company for annual and interim periods beginning after December 15, 2016. Early adoption is permitted. The Company expects to adopt this new standard as of December 31, 2016. The Company does not expect this ASU to have a material impact on its consolidated financial statements. On May 8, 2015, the FASB issued ASU 2015-08, “Business Combinations (Topic 805) Pushdown Accounting In April 2015, the Financial Accounting Standards Board issued Accounting Standards Update No. 2015-03, "Simplifying the Presentation of Debt Issuance Costs,"

NATURE OF OPERATIONS AND SUMM18

NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Tables)	9 Months Ended
	Mar. 31, 2016
Accounting Policies [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	Changes in Accumulated Other Comprehensive Income (Loss) by Component during the nine months ended March 31, 2016 was as follows: Foreign Beginning balance, June 30, 2015 $ 100,968 Foreign currency translation loss (126,413) Ending balance, March 31, 2016 $ (25,445)

CONVERTIBLE NOTES (Tables)

CONVERTIBLE NOTES (Tables)	9 Months Ended
	Mar. 31, 2016
Debt Disclosure [Abstract]
Schedule of convertible debenture [Table Text Block]	Convertible notes at March 31, 2016 were as follows: Convertible notes and debenture $ 3,352,199 Unamortized discounts (2,770,210) Accrued interest 65,281 Premium 351,819 Convertible notes, net $ 999,089

DERIVATIVE FINANCIAL INSTRUME20

DERIVATIVE FINANCIAL INSTRUMENTS and FAIR VALUE MEASUREMENTS (Tables)	9 Months Ended
	Mar. 31, 2016
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	The following tables summarize the Company’s financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2016: Balance at Quoted Prices Significant March in Active Other Significant 31, Markets for Observable Unobservable 2016 Identical Assets Inputs Inputs (Level 1) (Level 2) (Level 3) Embedded conversion option liabilities $ 3,659,506 $ — $ — $ 3,659,506 Fair value of liability for warrant derivative instruments $ 80,630 $ — $ — $ 80,630 Total $ 3,740,136 $ — $ — $ 3,740,136
Schedule of Derivative Liabilities at Fair Value [Table Text Block]	The following is a roll forward for the nine months ended March 31, 2016 of the fair value liability of price adjustable derivative instruments: Fair Value of Liability for Derivative Instruments Balance at June 30, 2015 $ 1,049,929 Effects of foreign currency exchange rate changes (10,490) Initial fair value of embedded conversion option derivative liability recorded as debt discount 2,205,925 Initial fair value of embedded conversion option derivative liability recorded as change in fair value of ECO 2,211,529 Change in fair value included in statements of operations (1,716,757) Balance at March 31, 2016 $ 3,740,136
Warrant [Member] | Convertible Debt [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block]	Warrants March 31, 2016 Volatility 217 % Expected remaining term 2.50 Risk-free interest rate 1.31 % Expected dividend yield none Convertible Debt Initial Valuations March 31, Volatility 217 % 217 % Expected Remaining Term 0.70 0.58 Risk Free Interest Rate 0.7 % 0.6 % Expected dividend yield none none

NATURE OF OPERATIONS AND SUMM21

NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Details) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Mar. 31, 2016	Mar. 31, 2015
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance, June 30, 2015			$ 100,968
Foreign currency translation gain / loss	$ (238,292)	$ 131,659	(126,413)	$ 349,796
Ending balance, March 31, 2016	$ (25,445)		$ (25,445)

NATURE OF OPERATIONS AND SUMM22

NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Mar. 31, 2016	Mar. 31, 2015	Jun. 30, 2015
Accumulated Other Comprehensive Income (Loss) [Line Items]
GST tax receivable	$ 21,628		$ 21,628		$ 11,647
Research and development	$ 510,301	$ 9,475	$ 806,578	$ 15,797
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount			520,153,814
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount			37,569,634

GOING CONCERN (Details Textual)

GOING CONCERN (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Mar. 31, 2016	Mar. 31, 2015	Jun. 30, 2015
Going Concern [Line Items]
Net loss	$ (2,151,909)	$ (454,250)	$ (6,552,870)	$ (1,586,167)
Net Cash Used In Operating Activities			2,205,144	$ 697,541
Stockholders Equity	(3,520,873)		(3,520,873)		$ (3,053,516)
Working Capital Deficit	3,526,238		3,526,238
Retained Earnings (Accumulated Deficit)	$ (27,518,541)		$ (27,518,541)		$ (20,965,671)

DUE TO DIRECTORS - RELATED PA24

DUE TO DIRECTORS - RELATED PARTIES (Details Textual) - USD ($)	Mar. 31, 2016	Jun. 30, 2015
Related Party Transaction [Line Items]
Due to Related Parties, Current	$ 35,168	$ 35,108

LOANS (Details Textual)

LOANS (Details Textual)	9 Months Ended
	Mar. 31, 2016USD ($)	Mar. 31, 2016AUD	Mar. 31, 2015USD ($)	Jun. 30, 2015USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Long-term Debt, Gross	$ 4,350,000
Repayments of Related Party Debt	21,491	AUD 29,744
Notes Payable, Current	2,300			$ 27,558
Repayments of Other Debt	23,843	AUD 33,000	$ 0
Foreign Currency Transaction Gain (Loss), Unrealized	47,366		$ (77,661)
Directors and Officer [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Long-term Debt, Gross	$ 56,743			$ 79,416

CONVERTIBLE NOTES (Details)

CONVERTIBLE NOTES (Details) - USD ($)	Mar. 31, 2016	Jun. 04, 2015	Aug. 06, 2014
Debt Instrument [Line Items]
Convertible notes and debenture	$ 4,350,000
Unamortized discounts		$ (20,000)	$ (25,000)
Convertible Notes Payable [Member]
Debt Instrument [Line Items]
Convertible notes and debenture	3,352,199
Unamortized discounts	(2,770,210)
Accrued interest	65,281
Premium	351,819
Convertible notes, net	$ 999,089

CONVERTIBLE NOTES (Details Text

CONVERTIBLE NOTES (Details Textual) - USD ($)	Feb. 10, 2016	Dec. 10, 2015	Mar. 12, 2015	Aug. 06, 2014	Feb. 17, 2016	Jul. 15, 2015	May. 19, 2015	Apr. 27, 2015	Apr. 24, 2015	Apr. 20, 2015	Mar. 20, 2015	Feb. 15, 2015	Mar. 31, 2016	Jun. 30, 2015	Dec. 30, 2015	Jun. 04, 2015
Debt Instrument [Line Items]
Debt Instrument, Face Amount				$ 250,000
Debt Instrument, Unamortized Discount				25,000												$ 20,000
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger							55.00%						22.50%
Six Month Consulting Agreement [Member]
Debt Instrument [Line Items]
Debt Instrument, Increase, Accrued Interest													$ 5,527
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger												60.00%
Debt Instrument, Periodic Payment, Principal													90,000
Additionally Debt Instrument Unamortized Premium													$ 60,000
Convertible Notes Payable [Member]
Debt Instrument [Line Items]
Proceeds from Issuance of Debt				25,000
Debt Issuance Cost				2,500
Convertible Notes Payable One [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount				250,000
Debt Instrument, Unamortized Discount				$ 25,000
Debt Instrument, Convertible, Terms of Conversion Feature	The note is convertible at the option of the holder at any time after 180 days at a rate of 55% of the lowest trading bid price of the Companys common stock for the ten prior trading days prior to the date upon which the conversion notice was received.
Percentage of Consideration Received				10.00%
Interest Rate on Payment of Consideration				0.00%
Debt Instrument, Interest Rate During Period				12.00%									12.00%
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger				60.00%
Debt Instrument, Periodic Payment, Principal		$ 27,500
Debt Instrument, Convertible, Stock Price Trigger				$ 0.09
Debt Instrument, Periodic Payment, Interest		3,607
Additionally Debt Instrument Unamortized Premium		90,000
Prepayment Penalties		$ 58,893
Convertible Notes Payable Two [Member]
Debt Instrument [Line Items]
Debt Instrument, Convertible, Terms of Conversion Feature					The note is convertible at the option of the holder at any time after 180 days at a rate of 55% of the lowest trading bid price of the Companys common stock for the ten prior trading days prior to the date upon which the conversion notice was received.
Interest and Debt Expense													$ 9,409
Debt Instrument, Periodic Payment, Principal													45,000
Debt Instrument, Periodic Payment, Interest													1,887
Additionally Debt Instrument Unamortized Premium													36,818
Convertible Notes Payable Three [Member]
Debt Instrument [Line Items]
Interest and Debt Expense													9,409	$ 27,409
Debt Instrument, Periodic Payment, Principal													45,000
Debt Instrument, Periodic Payment, Interest													2,229
Additionally Debt Instrument Unamortized Premium													36,818		$ 36,818
Convertible Notes Payable Four [Member]
Debt Instrument [Line Items]
Debt Instrument, Periodic Payment, Principal													170,500
Debt Instrument, Periodic Payment, Interest													8,580
Additionally Debt Instrument Unamortized Premium													139,500
Convertible Notes Payable Five [Member]
Debt Instrument [Line Items]
Debt Instrument, Periodic Payment, Principal													150,000
Debt Instrument, Periodic Payment, Interest													9,436
Additionally Debt Instrument Unamortized Premium													122,727
Convertible Back-End Notes Payable [Member]
Debt Instrument [Line Items]
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger											55.00%
Convertible Note Payable Eight [Member]
Debt Instrument [Line Items]
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger			58.00%
Interest and Debt Expense													6,276	46,441
Debt Instrument, Periodic Payment, Principal			$ 104,000			$ 104,000
Debt Instrument, Periodic Payment, Interest						2,872
Additionally Debt Instrument Unamortized Premium						137,915							22,593
Prepayment Penalties						$ 31,043
Convertible Note Payable Nine [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount										$ 17,500
Debt Instrument, Increase, Accrued Interest													79
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger										55.00%
Debt Instrument, Periodic Payment, Principal													16,500
Debt Instrument, Periodic Payment, Interest													803
Additionally Debt Instrument Unamortized Premium													13,500
Convertible Notes Payable Ten [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount									$ 45,000
Debt Instrument, Unamortized Discount									$ 7,500
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger									55.00%
Interest and Debt Expense													22,909	13,909
Debt Instrument, Periodic Payment, Principal													45,000
Debt Instrument, Periodic Payment, Interest													1,765
Additionally Debt Instrument Unamortized Premium													36,818
Convertible Notes Payable Eleven [Member]
Debt Instrument [Line Items]
Debt Instrument, Increase, Accrued Interest													3,308
Debt Instrument, Unamortized Discount									$ 7,500
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger									55.00%
Interest and Debt Expense													22,909	$ 13,909
Debt Instrument, Periodic Payment, Principal									$ 45,000				1,000
Debt Instrument, Periodic Payment, Interest													46
Additionally Debt Instrument Unamortized Premium													818
Convertible Notes Payable Twelve [Member]
Debt Instrument [Line Items]
Debt Instrument, Unamortized Discount								$ 13,000
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger								55.00%
Debt Instrument, Periodic Payment, Principal													170,500
Debt Instrument, Periodic Payment, Interest													8,303
Additionally Debt Instrument Unamortized Premium													$ 139,500

CONVERTIBLE NOTES (Details Te28

CONVERTIBLE NOTES (Details Textual 1)

Feb. 10, 2016

Jul. 14, 2015USD ($)

Jun. 04, 2015USD ($)$ / shares

Mar. 12, 2015USD ($)$ / shares

Jan. 02, 2015USD ($)

Oct. 31, 2015USD ($)

Oct. 28, 2015USD ($)$ / sharesshares

Jul. 15, 2015USD ($)

May. 19, 2015USD ($)

Apr. 27, 2015USD ($)

Apr. 24, 2015USD ($)

Apr. 20, 2015USD ($)

Mar. 20, 2015USD ($)

Feb. 17, 2015USD ($)

Feb. 15, 2015USD ($)

Mar. 31, 2016USD ($)$ / sharesshares

Mar. 31, 2015USD ($)

Feb. 22, 2016$ / shares

Dec. 09, 2015USD ($)

Jun. 30, 2015$ / shares

Feb. 10, 2015USD ($)

Aug. 06, 2014USD ($)

Debt Instrument [Line Items]

Debt Instrument, Face Amount

$ 250,000

Debt Instrument, Unamortized Discount

$ 20,000

$ 25,000

Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger

55.00%

22.50%

Net Proceeds From Notes Issued

$ 201,997

Amortization of debt discount

$ 2,235,257

$ 167,535

Debt Conversion, Converted Instrument, Amount

$ 0

152,285

Debt Instrument, Convertible, Conversion Price | $ / shares

$ 0.07

$ 0.03

Convertible Notes Payable

$ 352,500

$ 782,500

$ 782,500

Debt Convertible Note cash Purchase

$ 220,000

Debt Instrument, Increase (Decrease), Other, Net

$ 50,000

Proceeds from Interest Received

1,997

Proceeds from Sale of Notes Receivable

17,690

Warrants Term

4 years

Common stock, par value | $ / shares

$ 0.001

$ 0.001

Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares

$ 0.60

$ 0.045

Debt Discounts For Fees Paid

$ 4,207,500

166,500

Receivable From Deposit Control Account Non Current

1,200,000

Receivable From Deposit Control Account Current

$ 375,000

Debt Instrument Maximum Conversion Percentage On Trading Volume

25.00%

Common Stock, Capital Shares Reserved for Future Issuance | shares

300,000,000

Long-term Debt, Gross

$ 4,350,000

Six Month Consulting Agreement [Member]

Debt Instrument [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

5.00%

Debt Instrument, Maturity Date

Aug. 15, 2015

Debt Instrument, Unamortized Premium

$ 60,000

Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger

60.00%

Debt Instrument, Increase, Accrued Interest

5,527

Additionally Debt Instrument Unamortized Premium

60,000

Debt Conversion, Converted Instrument, Amount

$ 90,000

Debt Instrument, Periodic Payment, Principal

90,000

Two Year Consulting Agreement [Member]

Debt Instrument [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

10.00%

Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger

75.00%

Debt Conversion, Converted Instrument, Amount

$ 60,000

Interest Payable

5,159

Debt Instrument, Convertible, Conversion Price | $ / shares

$ 0.0175

Debt Instrument, Periodic Payment, Principal

$ 60,000

Convertible Note Payable [Member]

Debt Instrument [Line Items]

Debt Instrument, Face Amount

1,215,000

Debt Instrument, Interest Rate, Stated Percentage

24.00%

Debt Instrument, Unamortized Discount

$ 110,000

Debt Instrument, Percentage of Repayment, If prepaid within 60 days of the issuance date

130.00%

Debt Instrument, Percentage of Repayment, if prepaid 60 but less than 121 days after the issuance date

140.00%

Debt Instrument, Percentage of Repayment, if prepaid 120 but less than 180 days after the issuance date

150.00%

Proceeds from Notes Payable

$ 1,150,000

Additionally Debt Instrument Unamortized Premium

$ 269,976

Percentage of Consideration Received

10.00%

Debt Instrument, Periodic Payment, Principal

$ 285,024

Debt Instrument, Periodic Payment, Interest

29,091

Promissory Note Payable Issued For Services

$ 50,000

Debt Instrument, Description

The Company issued the Promissory Note with a principal amount of $1,200,000 to the Lender. The Promissory Note has a maturity date of the earlier of: (i) the date on which the Company closes a subsequent equity offering in an amount greater than the principal amount of the Promissory Note; or (ii) June 24, 2016. On its face, the Promissory Note does not accrue any interest. In the event that the Lender does not proceed with a subsequent financing, beginning on the 46th day following the Issuance Date, the Note will have a one-time interest adjustment of $180,000 on the outstanding principal of the Promissory Note. Additionally, if the Lender does not wish to proceed with a subsequent financing, the Promissory Note will also be convertible into common stock at the lower of (i) $0.0346; or (ii) a twenty percent (20%) discount to the average of the two lowest closing prices of the common stock in the five trading days prior to the date of conversion.

Convertible Note Payable Two [Member]

Debt Instrument [Line Items]

Debt Instrument, Face Amount

$ 45,000

Debt Instrument, Interest Rate, Stated Percentage

8.00%

Debt Instrument, Maturity Date

Feb. 10, 2016

Debt Instrument, Unamortized Discount

$ 7,500

Debt Instrument, Convertible, Threshold Trading Days

180

Convertible Note Payable Three [Member]

Debt Instrument [Line Items]

Debt Instrument, Face Amount

$ 45,000

Debt Instrument, Interest Rate, Stated Percentage

8.00%

Debt Instrument, Maturity Date

Feb. 17, 2016

Debt Instrument, Unamortized Discount

$ 7,500

Debt Instrument, Convertible, Threshold Trading Days

180

Convertible Note Payable Four [Member]

Debt Instrument [Line Items]

Debt Instrument, Face Amount

$ 170,500

Debt Instrument, Interest Rate, Stated Percentage

8.00%

Debt Instrument, Maturity Date

Mar. 12, 2016

Debt Instrument, Unamortized Discount

$ 13,000

Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger

55.00%

Additionally Debt Instrument Unamortized Premium

$ 139,500

Convertible Note Payable Five [Member]

Debt Instrument [Line Items]

Debt Instrument, Face Amount

$ 150,000

Debt Instrument, Interest Rate, Stated Percentage

8.00%

Debt Instrument, Unamortized Premium

$ 122,727

Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger

55.00%

Convertible Back-End Note Payable One [Member]

Debt Instrument [Line Items]

Debt Instrument, Face Amount

45,000

Convertible Back-End Note Payable Two [Member]

Debt Instrument [Line Items]

Debt Instrument, Face Amount

45,000

Convertible Back-End Note Payable Three [Member]

Debt Instrument [Line Items]

Debt Instrument, Face Amount

170,500

Convertible Back-End Note Payable Four [Member]

Debt Instrument [Line Items]

Debt Instrument, Face Amount

150,000

Convertible Note Payable Eight [Member]

Debt Instrument [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

8.00%

Debt Instrument, Unamortized Premium

$ 75,310

Debt Instrument, Convertible, Threshold Trading Days

180

Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger

58.00%

Additionally Debt Instrument Unamortized Premium

$ 137,915

22,593

Debt Instrument, Periodic Payment, Principal

$ 104,000

104,000

Prepayment Penalties

31,043

Debt Instrument, Periodic Payment, Interest

$ 2,872

Convertible Notes Payable Ten [Member]

Debt Instrument [Line Items]

Debt Instrument, Face Amount

$ 45,000

Debt Instrument, Maturity Date

Feb. 10, 2015

Debt Instrument, Unamortized Discount

$ 7,500

Debt Instrument, Unamortized Premium

$ 36,818

Debt Instrument, Convertible, Threshold Trading Days

180

Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger

55.00%

Legal Fees

$ 2,250

Net Proceeds From Notes Issued

$ 35,250

Additionally Debt Instrument Unamortized Premium

36,818

Debt Instrument, Periodic Payment, Principal

45,000

Debt Instrument, Periodic Payment, Interest

1,765

Convertible Notes Payable Eleven [Member]

Debt Instrument [Line Items]

Debt Instrument, Maturity Date

Feb. 17, 2015

Debt Instrument, Unamortized Discount

$ 7,500

Debt Instrument, Unamortized Premium

$ 36,818

Debt Instrument, Convertible, Threshold Trading Days

180

Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger

55.00%

Debt Instrument, Increase, Accrued Interest

3,308

Legal Fees

$ 2,250

Net Proceeds From Notes Issued

35,250

Additionally Debt Instrument Unamortized Premium

818

Debt Instrument, Periodic Payment, Principal

$ 45,000

1,000

Debt Instrument, Periodic Payment, Interest

46

Convertible Notes Payable Twelve [Member]

Debt Instrument [Line Items]

Debt Instrument, Maturity Date

Mar. 12, 2015

Debt Instrument, Unamortized Discount

$ 13,000

Debt Instrument, Unamortized Premium

$ 139,500

Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger

55.00%

Legal Fees

$ 7,500

Net Proceeds From Notes Issued

$ 150,000

Additionally Debt Instrument Unamortized Premium

139,500

Debt Instrument, Periodic Payment, Principal

170,500

Debt Instrument, Periodic Payment, Interest

8,303

Convertible Promissory Back-End Notes One [Member]

Debt Instrument [Line Items]

Convertible Notes Payable

37,500

Convertible Promissory Back-End Notes Two [Member]

Debt Instrument [Line Items]

Convertible Notes Payable

37,500

Convertible Promissory Back-End Notes Three [Member]

Debt Instrument [Line Items]

Convertible Notes Payable

157,500

Convertible Promissory Back-End Notes Four [Member]

Debt Instrument [Line Items]

Convertible Notes Payable

150,000

Convertible Promissory Back-End Notes Five [Member]

Debt Instrument [Line Items]

Convertible Notes Payable

17,500

Convertible Promissory Back-End Notes Six [Member]

Debt Instrument [Line Items]

Convertible Notes Payable

37,500

Convertible Promissory Back-End Notes Seven [Member]

Debt Instrument [Line Items]

Convertible Notes Payable

37,500

Convertible Promissory Back-End Notes Eight [Member]

Debt Instrument [Line Items]

Convertible Notes Payable

157,500

Convertible Promissory Back-End Notes Nine [Member]

Debt Instrument [Line Items]

Convertible Notes Payable

$ 150,000

Convertible Notes Payable Fourteen [Member]

Debt Instrument [Line Items]

Debt Instrument, Unamortized Premium

288,409

Debt Instrument, Increase, Accrued Interest

3,558

Net Proceeds From Notes Issued

334,810

Additionally Debt Instrument Unamortized Premium

$ 288,409

235,227

Debt Instrument, Periodic Payment, Principal

287,500

Debt Instrument, Periodic Payment, Interest

15,184

Secured Investor Note One [Member]

Debt Instrument [Line Items]

Debt Instrument, Unamortized Discount

$ 30,000

Legal Fees

5,000

Debt Convertible Note cash Purchase

335,000

Secured Investor Note Two [Member]

Debt Instrument [Line Items]

Debt Instrument, Unamortized Discount

20,000

Debt Convertible Note cash Purchase

220,000

Secured Investor Note Three [Member]

Debt Instrument [Line Items]

Debt Instrument, Unamortized Discount

20,000

Debt Convertible Note cash Purchase

$ 220,000

Execution Note [Member]

Debt Instrument [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

10.00%

Debt Instrument, Unamortized Discount

$ 30,000

Legal Fees

$ 5,000

Debt Instrument, Convertible, Conversion Price | $ / shares

$ 0.07

Debt Convertible Note cash Purchase

$ 300,000

Secured Debt, Secured Percentage by Lender

40.00%

Market Capitalization Minimum Amount

$ 3,000,000

Convertible Note Payable Nine [Member]

Debt Instrument [Line Items]

Debt Instrument, Face Amount

$ 17,500

Debt Instrument, Interest Rate, Stated Percentage

8.00%

Debt Instrument, Unamortized Premium

$ 14,318

Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger

55.00%

Debt Instrument, Increase, Accrued Interest

79

Additionally Debt Instrument Unamortized Premium

13,500

Debt Instrument, Periodic Payment, Principal

16,500

Debt Instrument, Periodic Payment, Interest

803

Convertible Notes Payable Thirteen [Member]

Debt Instrument [Line Items]

Debt Instrument, Unamortized Premium

$ 122,727

Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger

55.00%

Debt Instrument, Increase, Accrued Interest

2,329

Proceeds from Notes Payable

$ 150,000

Legal Fees

7,500

Net Proceeds From Notes Issued

$ 142,500

Additionally Debt Instrument Unamortized Premium

102,273

Debt Instrument, Periodic Payment, Principal

125,000

Debt Instrument, Periodic Payment, Interest

8,849

Securities Purchase Agreement [Member]

Debt Instrument [Line Items]

Debt Instrument, Face Amount

$ 4,400,000

Debt Instrument, Increase (Decrease), Other, Net

25,000

Cancellation Of Debt

1,200,000

Debt Issuance Cost

$ 50,000

Warrant Issued To Purchase Of Shares | shares

26,190,476

Common stock, par value | $ / shares

$ 0.001

Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares

$ 0.60

Amount Will Be Deposited Into Deposit Control Account

$ 2,800,000

Debt Instrument Increase Decrease Reason For Registration Effective

$ 25,000

Debenture [Member]

Debt Instrument [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

5.00%

Debt Instrument, Debt Default, Interest Rate

18.00%

Debt Instrument, Description

payable quarterly in cash (or if certain conditions are met, in stock at the Companys option) on January 1, April 1, July 1 and October 1. The Debenture was, prior to Addendum, convertible at any time, in whole or in part, at the Purchasers option into shares of the Companys common stock, par value $0.001 per share (the Common Stock), at a conversion price equal to $0.042, which is the volume weighted average price of the Companys Common Stock five days prior to the execution of the Debenture (subject to adjustment) (the Conversion Price). At any time after the effective date of the registration statement, the Purchaser has the opportunity to convert up to an aggregate of $2,090,000 of the Debenture, at one or more conversion dates, into shares of Common Stock at a conversion price equal to the VWAP of the Common Stock over the five (5) trading days prior to such Effective Date. The Purchaser option to convert at such a conversion price expires when the Purchaser converts an aggregate of $2,090,000 of the Debenture using such conversion price. If the volume weighted average price of the Company Common Stock on any trading day is less than the Conversion Price, the Purchaser may convert at a price per share equal to a twenty percent (20%) discount to the average of the two lowest closing prices during the five trading days prior to the date of conversion. At no time will the Purchaser be entitled to convert any portion of the Debenture to the extent that after such conversion, the Purchaser (together with its affiliates) would beneficially own more than 4.99% of the outstanding shares of Common Stock as of such date. During the nine months ended March 31, 2016, the Company withdrew a principal amount of $2,425,000 from the deposit control account, of which $269,976 was paid directly as partial payment of a note dated June 4, 2015 and $33,437 were paid directly to legal fees resulting in net cash proceeds of $2,121,587 received by the Company. An aggregate total of $3,290,000 of these notes were bifurcated with the embedded conversion option recorded as a derivative liability at fair value (See Note 10). During the nine months ended March 31, 2016, the Company converted $1,065,301 of principal into shares of the Companys common stock (See Note 6). Accrued interest as of March 31, 2016 was $44,794.

Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares

$ 0.60

Discount On Debt Issued Percentage

10.00%

Debt Discounts [Member]

Debt Instrument [Line Items]

Amortization of debt discount

1,852,757

$ 43,773

Convertible Notes Payable Fifteen [Member]

Debt Instrument [Line Items]

Debt Instrument, Increase, Accrued Interest

11,213

Additionally Debt Instrument Unamortized Premium

110,455

Debt Instrument, Periodic Payment, Principal

135,000

Debt Instrument, Periodic Payment, Interest

$ 4,702

STOCKHOLDERS' DEFICIT (Details

STOCKHOLDERS' DEFICIT (Details Textual) - USD ($)	Mar. 15, 2016	Mar. 13, 2016	Mar. 08, 2016	Mar. 04, 2016	Mar. 02, 2016	Feb. 12, 2016	Feb. 10, 2016	Feb. 09, 2016	Feb. 08, 2016	Feb. 04, 2016	Feb. 03, 2016	Feb. 01, 2016	Jan. 14, 2016	Jan. 13, 2016	Jan. 12, 2016	Jan. 11, 2016	Jan. 08, 2016	Jan. 06, 2016	Jan. 04, 2016	Dec. 28, 2015	Dec. 23, 2015	Dec. 21, 2015	Dec. 17, 2015	Dec. 16, 2015	Dec. 15, 2015	Dec. 11, 2015	Dec. 10, 2015	Dec. 08, 2015	Dec. 04, 2015	Nov. 30, 2015	Nov. 24, 2015	Nov. 23, 2015	Nov. 11, 2015	Oct. 16, 2015	Oct. 15, 2015	Oct. 13, 2015	Oct. 08, 2015	Oct. 07, 2015	Oct. 03, 2015	Sep. 16, 2015	Sep. 08, 2015	Sep. 04, 2015	Aug. 14, 2015	Jul. 02, 2015	Jun. 16, 2015	Jun. 04, 2015	Dec. 09, 2014	Apr. 30, 2016	Mar. 29, 2016	Mar. 18, 2016	Feb. 26, 2016	Feb. 25, 2016	Feb. 23, 2016	Feb. 22, 2016	Feb. 18, 2016	Feb. 17, 2016	Feb. 16, 2016	Jan. 29, 2016	Jan. 27, 2016	Jan. 25, 2016	Jan. 21, 2016	Jan. 20, 2016	Jan. 19, 2016	Dec. 31, 2015	Dec. 30, 2015	Dec. 29, 2015	Nov. 17, 2015	Oct. 31, 2015	Oct. 28, 2015	Sep. 22, 2015	Sep. 18, 2015	Sep. 01, 2015	Aug. 26, 2015	Jul. 24, 2015	Mar. 31, 2016	Dec. 31, 2014	Mar. 31, 2016	Jul. 10, 2015	Jun. 30, 2015	Nov. 12, 2014
Debt Instrument, Convertible, Conversion Price																																														$ 0.07																													$ 0.03		$ 0.03
Stock Issued During Period, Shares, New Issues																																																																				1,500,000
Warrants Expire Period																																																																					4 years
Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants																																																						$ 4,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights																																																						$ 0.045															$ 0.60
Stock Issued During Period, Shares, Issued for Services																																																																													71,500,000
Stock Issued During Period, Value, Issued for Services																																																																													$ 2,056,059
Common Stock, Shares Authorized																																																																											2,000,000,000		2,000,000,000		2,000,000,000
Common stock, par value																																																																											$ 0.001		$ 0.001		$ 0.001
Class of Warrant or Right, Outstanding																																																																											37,569,634		37,569,634
Share Price																																																																											$ 0.0304		$ 0.0304
Warrants To Purchase Of Common Stock																																																																					$ 26,190,476
Scientific Advisory Board [Member]
Stock Issued During Period, Shares, Issued for Services																																									600,000
Shares Issued, Price Per Share																																									$ 0.0369
Stock Issued During Period, Value, Issued for Services																																									$ 22,140
Common Stock [Member]
Common Stock, Shares Authorized																																																																											2,000,000,000		2,000,000,000	10,000,000,000	10,000,000,000	100,000,000
Common stock, par value																																																																											$ 0.001		$ 0.001	$ 0.001	$ 0.001	$ 0.001
Preferred Stock [Member]
Preferred stock, authorized shares																																																																											10,000,000		10,000,000
Preferred stock, par value																																																																											$ 0.01		$ 0.01
Consultant [Member]
Stock Issued During Period, Shares, New Issues																																	2,000,000																															1,600,000
Stock Issued During Period, Shares, Issued for Services																																					8,000,000				600,000			500,000		500,000		1,500,000																				1,500,000					560,000
Shares Issued, Price Per Share																																		$ 0.0415												$ 0.0706																						$ 0.031
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized																																																																				400,000
Consulting Expenses																																		$ 166,000												$ 35,300																						$ 46,500									$ 30,285
Consultant [Member] | Common Stock [Member]
Stock Issued During Period, Shares, Issued for Services																			1,000,000															4,000,000																															1,000,000
Shares Issued, Price Per Share																																																																	$ 0.0260
Share Price																																																						$ 0.0119
Consulting Expenses																																																																	$ 26,000												22,400
Consultant [Member] | Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate																																																						314.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term																																																						60 months
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate																																																						1.54%
Warrants and Rights Outstanding																																																						$ 47,560
Prepaid Expense																																																																											$ 10,714		10,714
Share-based Compensation, Total																																																																											$ 36,846
Consultant One [Member]
Stock Issued During Period, Shares, New Issues																																																																	1,000,000			1,100,000						8,000,000
Stock Issued During Period, Shares, Issued for Services																																		4,000,000																																								8,000,000
Shares Issued, Price Per Share																																																																										$ 0.0435
Consulting Expenses																																																																										$ 348,000			151,486
Consultant One [Member] | Common Stock [Member]
Consulting Expenses																																																																													8,730
Consultant Two [Member]
Stock Issued During Period, Shares, New Issues																											2,250,000
Consulting Expenses																																																																													348,000
Consultant Two [Member] | Common Stock [Member]
Stock Issued During Period, Shares, Issued for Services																																																							375,000										2,250,000
Shares Issued, Price Per Share																																																																	$ 0.0279
Stock Issued During Period, Value, Issued for Services																																																																	$ 62,775
Consulting Expenses																																																																													20,925
Consultant Three [Member]
Consulting Expenses																																																																													23,314
Consultant Three [Member] | Common Stock [Member]
Stock Issued During Period, Shares, Issued for Services																			1,600,000																																													1,600,000
Shares Issued, Price Per Share																																																																$ 0.0279
Stock Issued During Period, Value, Issued for Services																																																																$ 44,640
Consultant Four [Member] | Common Stock [Member]
Stock Issued During Period, Shares, Issued for Services																																	2,000,000																							2,000,000
Shares Issued, Price Per Share																																	$ 0.0157
Consulting Expenses																																	$ 31,400																																												$ 24,326
Issue One [Member]
Debt Instrument, Convertible, Conversion Price																																											$ 0.02365
Debt Conversion, Converted Instrument, Shares Issued																																											866,796
Stock Issued During Period, Shares, Issued for Services																																																																									560,000
Shares Issued, Price Per Share																																																																									$ 0.04
Debt Conversion, Original Debt, Amount																																											$ 20,500
Issue Two [Member]
Debt Instrument, Convertible, Conversion Price																																											$ 0.02365
Debt Conversion, Converted Instrument, Shares Issued																																											879,585
Debt Conversion, Original Debt, Amount																																											$ 20,802
Issue Three [Member]
Debt Instrument, Convertible, Conversion Price																																																																									$ 0.018425
Debt Conversion, Converted Instrument, Shares Issued																																																																									1,414,843
Debt Conversion, Original Debt, Amount																																																																									$ 26,068
Issue Four [Member]
Debt Instrument, Convertible, Conversion Price																																																																								$ 0.018425
Debt Conversion, Converted Instrument, Shares Issued																																																																								1,396,108
Debt Conversion, Original Debt, Amount																																																																								$ 25,723
Issue Five [Member]
Debt Instrument, Convertible, Conversion Price																																										$ 0.018425
Debt Conversion, Converted Instrument, Shares Issued																																										849,263
Debt Conversion, Original Debt, Amount																																										$ 15,648
Issue Six [Member]
Debt Instrument, Convertible, Conversion Price																																								$ 0.018975
Debt Conversion, Converted Instrument, Shares Issued																																								826,726
Debt Conversion, Original Debt, Amount																																								$ 15,687
Issue Six [Member] | Consultant [Member]
Stock Issued During Period, Shares, Issued for Services																																														500,000
Issue Seven [Member]
Debt Instrument, Convertible, Conversion Price																																																																							$ 0.017875
Debt Conversion, Converted Instrument, Shares Issued																																																																							877,969
Debt Conversion, Original Debt, Amount																																																																							$ 15,694
Issue Eight [Member]
Debt Instrument, Convertible, Conversion Price																																																																						$ 0.01716
Debt Conversion, Converted Instrument, Shares Issued																																																																						911,294
Debt Conversion, Original Debt, Amount																																																																						$ 15,638
Issue Nine [Member]
Debt Instrument, Convertible, Conversion Price																																							$ 0.012375
Debt Conversion, Converted Instrument, Shares Issued																																							2,152,289
Debt Conversion, Original Debt, Amount																																							$ 26,635
Issue Ten [Member]
Debt Instrument, Convertible, Conversion Price																																						$ 0.012375
Debt Conversion, Converted Instrument, Shares Issued																																						2,535,293
Debt Conversion, Original Debt, Amount																																						$ 31,374
Issue Eleven [Member]
Debt Instrument, Convertible, Conversion Price																																				$ 0.012375
Debt Conversion, Converted Instrument, Shares Issued																																				8,808,435
Debt Conversion, Original Debt, Amount																																				$ 109,004
Issue Twelve [Member]
Debt Instrument, Convertible, Conversion Price																																				$ 0.012375
Debt Conversion, Converted Instrument, Shares Issued																																				8,461,602
Debt Conversion, Original Debt, Amount																																				$ 104,712
Issue Thirteen [Member]
Debt Instrument, Convertible, Conversion Price																																			$ 0.01
Debt Conversion, Converted Instrument, Shares Issued																																			5,000,000
Debt Conversion, Original Debt, Amount																																			$ 50,000
Issue Fourteen [Member]
Debt Instrument, Convertible, Conversion Price																																																																			$ 0.01986
Debt Conversion, Converted Instrument, Shares Issued																																																																			105,709
Debt Conversion, Original Debt, Amount																																																																			$ 2,099
Issue Fifteen [Member]
Debt Instrument, Convertible, Conversion Price																																																																			$ 0.01
Debt Conversion, Converted Instrument, Shares Issued																																																																			3,500,000
Debt Conversion, Original Debt, Amount																																																																			$ 35,000
Issue Sixteen [Member]
Debt Instrument, Convertible, Conversion Price																																$ 0.0154
Debt Conversion, Converted Instrument, Shares Issued																																1,019,925
Debt Conversion, Original Debt, Amount																																$ 15,707
Issue Seventeen [Member]
Debt Instrument, Convertible, Conversion Price																															$ 0.0154
Debt Conversion, Converted Instrument, Shares Issued																															1,360,185
Debt Conversion, Original Debt, Amount																															$ 20,947
Issue Eighteen [Member]
Debt Instrument, Convertible, Conversion Price																														$ 0.0154
Debt Conversion, Converted Instrument, Shares Issued																														3,200,448
Debt Conversion, Original Debt, Amount																														$ 49,287
Issue Nineteen [Member]
Debt Instrument, Convertible, Conversion Price																													$ 0.0154
Debt Conversion, Converted Instrument, Shares Issued																													2,058,637
Debt Conversion, Original Debt, Amount																													$ 31,703
Issue Twenty [Member]
Debt Instrument, Convertible, Conversion Price																												$ 0.01595
Debt Conversion, Converted Instrument, Shares Issued																												3,963,207
Debt Conversion, Original Debt, Amount																												$ 63,213
Issue Twenty One [Member]
Debt Instrument, Convertible, Conversion Price																										$ 0.02608
Debt Conversion, Converted Instrument, Shares Issued																										1,917,178
Debt Conversion, Original Debt, Amount																										$ 50,000
Issue Twenty Two [Member]
Debt Instrument, Convertible, Conversion Price																									$ 0.02712
Debt Conversion, Converted Instrument, Shares Issued																									1,843,658
Debt Conversion, Original Debt, Amount																									$ 50,000
Issue Twenty Three [Member]
Debt Instrument, Convertible, Conversion Price																								$ 0.01650
Debt Conversion, Converted Instrument, Shares Issued																								1,926,177
Debt Conversion, Original Debt, Amount																								$ 31,782
Issue Twenty Four [Member]
Debt Instrument, Convertible, Conversion Price																							$ 0.02500
Debt Conversion, Converted Instrument, Shares Issued																							1,600,000
Debt Conversion, Original Debt, Amount																							$ 40,000
Issue Twenty Five [Member]
Debt Instrument, Convertible, Conversion Price																						$ 0.02360
Debt Conversion, Converted Instrument, Shares Issued																						1,694,916
Debt Conversion, Original Debt, Amount																						$ 40,000
Issue Twenty Six [Member]
Debt Instrument, Convertible, Conversion Price																						$ 0.01584
Debt Conversion, Converted Instrument, Shares Issued																						3,265,069
Debt Conversion, Original Debt, Amount																						$ 51,719
Issue Twenty Seven [Member]
Debt Instrument, Convertible, Conversion Price																					$ 0.02320
Debt Conversion, Converted Instrument, Shares Issued																					1,724,138
Debt Conversion, Original Debt, Amount																					$ 40,000
Issue Twenty Eight [Member]
Debt Instrument, Convertible, Conversion Price																					$ 0.01584
Debt Conversion, Converted Instrument, Shares Issued																					1,983,188
Debt Conversion, Original Debt, Amount																					$ 31,414
Issue Twenty Nine [Member]
Debt Instrument, Convertible, Conversion Price																				$ 0.02320
Debt Conversion, Converted Instrument, Shares Issued																				1,724,138
Debt Conversion, Original Debt, Amount																				$ 40,000
Issue Thirty [Member]
Debt Instrument, Convertible, Conversion Price																																																																		$ 0.01573
Debt Conversion, Converted Instrument, Shares Issued																																																																		999,783
Debt Conversion, Original Debt, Amount																																																																		$ 15,727
Issue Thirty One [Member]
Debt Instrument, Convertible, Conversion Price																																																																	$ 0.02284
Debt Conversion, Converted Instrument, Shares Issued																																																																	1,751,314
Debt Conversion, Original Debt, Amount																																																																	$ 40,000
Issue Thirty Two [Member]
Debt Instrument, Convertible, Conversion Price																			$ 0.0143
Debt Conversion, Converted Instrument, Shares Issued																			1,468,187
Debt Conversion, Original Debt, Amount																			$ 20,995
Issue Thirty Three [Member]
Debt Instrument, Convertible, Conversion Price																			$ 0.02156
Debt Conversion, Converted Instrument, Shares Issued																			2,522,032
Debt Conversion, Original Debt, Amount																			$ 54,375
Issue Thirty Four [Member]
Debt Instrument, Convertible, Conversion Price																		$ 0.02068
Debt Conversion, Converted Instrument, Shares Issued																		1,934,236
Debt Conversion, Original Debt, Amount																		$ 40,000
Issue Thirty Five [Member]
Debt Instrument, Convertible, Conversion Price																		$ 0.014135
Debt Conversion, Converted Instrument, Shares Issued																		1,485,946
Debt Conversion, Original Debt, Amount																		$ 21,004
Issue Thirty Six [Member]
Debt Instrument, Convertible, Conversion Price																	$ 0.02008
Debt Conversion, Converted Instrument, Shares Issued																	1,992,032
Debt Conversion, Original Debt, Amount																	$ 40,000
Issue Thirty Seven [Member]
Debt Instrument, Convertible, Conversion Price																	$ 0.0113805
Debt Conversion, Converted Instrument, Shares Issued																	761,050
Debt Conversion, Original Debt, Amount																	$ 10,506
Issue Thirty Eight [Member]
Debt Instrument, Convertible, Conversion Price																$ 0.01375
Debt Conversion, Converted Instrument, Shares Issued																764,573
Debt Conversion, Original Debt, Amount																$ 10,513
Issue Thirty Nine [Member]
Debt Instrument, Convertible, Conversion Price															$ 0.012705
Debt Conversion, Converted Instrument, Shares Issued															827,632
Debt Conversion, Original Debt, Amount															$ 10,515
Issue Forty [Member]
Debt Instrument, Convertible, Conversion Price														$ 0.01864
Debt Conversion, Converted Instrument, Shares Issued														946,889
Debt Conversion, Original Debt, Amount														$ 17,650
Issue Forty One [Member]
Debt Instrument, Convertible, Conversion Price														$ 0.011825
Debt Conversion, Converted Instrument, Shares Issued														889,409
Debt Conversion, Original Debt, Amount														$ 10,517
Issue Forty Two [Member]
Debt Instrument, Convertible, Conversion Price														$ 0.01056
Debt Conversion, Converted Instrument, Shares Issued														1,971,565
Debt Conversion, Original Debt, Amount														$ 20,820
Issue Forty Three [Member]
Debt Instrument, Convertible, Conversion Price													$ 0.0168
Debt Conversion, Converted Instrument, Shares Issued													4,901,786
Debt Conversion, Original Debt, Amount													$ 82,350
Issue Forty Four [Member]
Debt Instrument, Convertible, Conversion Price																																																															$ 0.009955
Debt Conversion, Converted Instrument, Shares Issued																																																															1,047,013
Debt Conversion, Original Debt, Amount																																																															$ 10,423
Issue Forty Five [Member]
Debt Instrument, Convertible, Conversion Price																																																														$ 0.009955
Debt Conversion, Converted Instrument, Shares Issued																																																														513,158
Debt Conversion, Original Debt, Amount																																																														$ 5,108
Issue Forty Six [Member]
Debt Instrument, Convertible, Conversion Price																																																													$ 0.01488
Debt Conversion, Converted Instrument, Shares Issued																																																													1,680,108
Debt Conversion, Original Debt, Amount																																																													$ 25,000
Issue Forty Seven [Member]
Debt Instrument, Convertible, Conversion Price																																																													$ 0.009955
Debt Conversion, Converted Instrument, Shares Issued																																																													1,256,944
Debt Conversion, Original Debt, Amount																																																													$ 12,513
Issue Forty Eight [Member]
Debt Instrument, Convertible, Conversion Price																																																												$ 0.01492
Debt Conversion, Converted Instrument, Shares Issued																																																												1,675,604
Debt Conversion, Original Debt, Amount																																																												$ 25,000
Issue Forty Nine [Member]
Debt Instrument, Convertible, Conversion Price																																																												$ 0.009955
Debt Conversion, Converted Instrument, Shares Issued																																																												1,362,834
Debt Conversion, Original Debt, Amount																																																												$ 13,567
Issue Fifty [Member]
Debt Instrument, Convertible, Conversion Price																																																												$ 0.0150
Debt Conversion, Converted Instrument, Shares Issued																																																												4,343,934
Debt Conversion, Original Debt, Amount																																																												$ 65,159
Issue Fifty One [Member]
Debt Instrument, Convertible, Conversion Price																																																											$ 0.009955
Debt Conversion, Converted Instrument, Shares Issued																																																											1,573,161
Debt Conversion, Original Debt, Amount																																																											$ 15,661
Issue Fifty Two [Member]
Debt Instrument, Convertible, Conversion Price																																																										$ 0.015080
Debt Conversion, Converted Instrument, Shares Issued																																																										1,657,825
Debt Conversion, Original Debt, Amount																																																										$ 25,000
Issue Fifty Three [Member]
Debt Instrument, Convertible, Conversion Price												$ 0.009955
Debt Conversion, Converted Instrument, Shares Issued												1,679,800
Debt Conversion, Original Debt, Amount												$ 16,722
Issue Fifty Four [Member]
Debt Instrument, Convertible, Conversion Price											$ 0.0148
Debt Conversion, Converted Instrument, Shares Issued											1,351,352
Debt Conversion, Original Debt, Amount											$ 20,000
Issue Fifty Five [Member]
Debt Instrument, Convertible, Conversion Price											$ 0.009405
Debt Conversion, Converted Instrument, Shares Issued											1,111,737
Debt Conversion, Original Debt, Amount											$ 10,456
Issue Fifty Six [Member]
Debt Instrument, Convertible, Conversion Price										$ 0.0142
Debt Conversion, Converted Instrument, Shares Issued										1,760,564
Debt Conversion, Original Debt, Amount										$ 25,000
Issue Fifty Seven [Member]
Debt Instrument, Convertible, Conversion Price										$ 0.009405
Debt Conversion, Converted Instrument, Shares Issued										2,779,927
Debt Conversion, Original Debt, Amount										$ 26,145
Issue Fifty Eight [Member]
Debt Instrument, Convertible, Conversion Price									$ 0.009405
Debt Conversion, Converted Instrument, Shares Issued									1,669,354
Debt Conversion, Original Debt, Amount									$ 15,700
Issue Fifty Nine [Member]
Debt Instrument, Convertible, Conversion Price								$ 0.0100
Debt Conversion, Converted Instrument, Shares Issued								19,814,000
Debt Conversion, Original Debt, Amount								$ 198,140
Issue Sixty [Member]
Debt Instrument, Convertible, Conversion Price								$ 0.0138
Debt Conversion, Converted Instrument, Shares Issued								1,811,595
Debt Conversion, Original Debt, Amount								$ 25,000
Issue Sixty One [Member]
Debt Instrument, Convertible, Conversion Price							$ 0.00864
Debt Conversion, Converted Instrument, Shares Issued							1,394,548
Debt Conversion, Original Debt, Amount							$ 12,042
Issue Sixty Two [Member]
Debt Instrument, Convertible, Conversion Price						$ 0.01268
Debt Conversion, Converted Instrument, Shares Issued						3,154,575
Debt Conversion, Original Debt, Amount						$ 40,000
Issue Sixty Three [Member]
Debt Instrument, Convertible, Conversion Price																																																									$ 0.00864
Debt Conversion, Converted Instrument, Shares Issued																																																									1,221,172
Debt Conversion, Original Debt, Amount																																																									$ 10,276
Issue Sixty Four [Member]
Debt Instrument, Convertible, Conversion Price																																																								$ 0.00787
Debt Conversion, Converted Instrument, Shares Issued																																																								1,306,848
Debt Conversion, Original Debt, Amount																																																								$ 10,278
Issue Sixty Five [Member]
Debt Instrument, Convertible, Conversion Price																																																						$ 0.00787
Debt Conversion, Converted Instrument, Shares Issued																																																						2,616,482
Debt Conversion, Original Debt, Amount																																																						$ 20,579
Issue Sixty Six [Member]
Debt Instrument, Convertible, Conversion Price																																																					$ 0.01184
Debt Conversion, Converted Instrument, Shares Issued																																																					2,533,784
Debt Conversion, Original Debt, Amount																																																					$ 30,000
Issue Sixty Seven [Member]
Debt Instrument, Convertible, Conversion Price																																																				$ 0.0100
Debt Conversion, Converted Instrument, Shares Issued																																																				11,597,463
Debt Conversion, Original Debt, Amount																																																				$ 115,975
Issue Sixty Eight [Member]
Debt Instrument, Convertible, Conversion Price																																																				$ 0.0100
Debt Conversion, Converted Instrument, Shares Issued																																																				3,000,000
Debt Conversion, Original Debt, Amount																																																				$ 30,000
Issue Sixty Nine [Member]
Debt Instrument, Convertible, Conversion Price																																																			$ 0.0096
Debt Conversion, Converted Instrument, Shares Issued																																																			3,275,110
Debt Conversion, Original Debt, Amount																																																			$ 30,000
Issue Seventy [Member]
Debt Instrument, Convertible, Conversion Price					$ 0.00567
Debt Conversion, Converted Instrument, Shares Issued					4,549,444
Debt Conversion, Original Debt, Amount					$ 25,773
Issue Seventy One [Member]
Debt Instrument, Convertible, Conversion Price				$ 0.00832
Debt Conversion, Converted Instrument, Shares Issued				6,009,616
Debt Conversion, Original Debt, Amount				$ 50,000
Issue Seventy Two [Member]
Debt Instrument, Convertible, Conversion Price			$ 0.00868
Debt Conversion, Converted Instrument, Shares Issued			16,474,655
Debt Conversion, Original Debt, Amount			$ 143,000
Issue Seventy Three [Member]
Debt Instrument, Convertible, Conversion Price		$ 0.00201
Debt Conversion, Converted Instrument, Shares Issued		4,107,483
Debt Conversion, Original Debt, Amount		$ 8,274
Issue Seventy Four [Member]
Debt Instrument, Convertible, Conversion Price	$ 0.00572
Debt Conversion, Converted Instrument, Shares Issued	22,123,958
Debt Conversion, Original Debt, Amount	$ 126,549
Issue Seventy Five [Member]
Debt Instrument, Convertible, Conversion Price																																																		$ 0.00660
Debt Conversion, Converted Instrument, Shares Issued																																																		10,187,380
Debt Conversion, Original Debt, Amount																																																		$ 67,237
Issue Seventy Six [Member]
Debt Instrument, Convertible, Conversion Price																																																	$ 0.01920
Debt Conversion, Converted Instrument, Shares Issued																																																	3,277,403
Debt Conversion, Original Debt, Amount																																																	$ 62,926
Series A Preferred Stock [Member]
Stock Issued During Period, Shares, New Issues																																																																												8,161,000
Preferred stock, authorized shares																																															500,000																												10,000,000		10,000,000		10,000,000
Preferred stock, par value																																															$ 0.01																												$ 0.01		$ 0.01		$ 0.01
Stock Issued During Period, Shares, Issued for Services																																															500,000
Shares Issued, Price Per Share																																																																												$ 0.00213
Stock Issued During Period, Value, New Issues																																																																												$ 1,067
Series B Preferred Stock [Member]
Preferred stock, authorized shares																																																																											5		5		5
Preferred stock, par value																																													$ 0.01																														$ 0.01		$ 0.01		$ 0.01
Shares Issued, Price Per Share																																													$ 0.1165
Stock Issued During Period, Value, Issued for Services																																													$ 0.12
Series B Preferred Stock [Member] | Chief Executive Officer [Member]
Stock Issued During Period, Shares, Issued for Services																																													1

COMMITMENTS AND CONTINGIENCIES

COMMITMENTS AND CONTINGIENCIES (Details Textual)	May. 05, 2016AUD	Dec. 31, 2015USD ($)	May. 31, 2015AUD	Nov. 30, 2009	Mar. 31, 2016USD ($)	Mar. 31, 2015USD ($)
Commitments And Contingencies [Line Items]
Operating Leases, Rent Expense					$ 15,062	$ 7,710
Promissory Note [Member]
Commitments And Contingencies [Line Items]
Repayments of Notes Payable		$ 90,000
Lease Agreements [Member]
Commitments And Contingencies [Line Items]
Payments for Fees | AUD	AUD 3,000		AUD 2,200
Royalty Agreement Terms [Member]
Commitments And Contingencies [Line Items]
Operating Leases Income Statement Revenue Percentage				2.00%
License Agreement Terms [Member]
Commitments And Contingencies [Line Items]
Operating Leases Income Statement Revenue Percentage				5.00%

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Textual) - USD ($)	Mar. 31, 2016	Jun. 30, 2015
Related Party Transaction [Line Items]
Due to Related Parties, Current	$ 35,168	$ 35,108
Loans From Related Party	56,743	79,416
Director [Member]
Related Party Transaction [Line Items]
Loans From Related Party	56,743	79,416
Two Directors [Member]
Related Party Transaction [Line Items]
Due to Related Parties, Current	$ 35,168	$ 35,108

CONCENTRATIONS AND RISKS (Detai

CONCENTRATIONS AND RISKS (Details Textual)	9 Months Ended	12 Months Ended
	Mar. 31, 2016	Jun. 30, 2015
Reimbursement On Goods And Service Tax Receivable Percentage	100.00%	100.00%

DERIVATIVE FINANCIAL INSTRUME33

DERIVATIVE FINANCIAL INSTRUMENTS and FAIR VALUE MEASUREMENTS (Details)	9 Months Ended
	Mar. 31, 2016
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Expected dividend yield	0.00%
Convertible Debt [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Volatility	217.00%
Expected remaining term	6 months 29 days
Risk-free interest rate	0.60%
Expected dividend yield	0.00%
Warrants [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Volatility	217.00%
Expected remaining term	2 years 6 months
Risk-free interest rate	1.31%
Initial Valuations On Derivative [Member] | Convertible Debt [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Volatility	217.00%
Expected remaining term	8 months 12 days
Risk-free interest rate	0.70%
Expected dividend yield	0.00%

DERIVATIVE FINANCIAL INSTRUME34

DERIVATIVE FINANCIAL INSTRUMENTS and FAIR VALUE MEASUREMENTS (Details 1) - USD ($)	Mar. 31, 2016	Jun. 30, 2015
Derivative [Line Items]
Embedded conversion option liabilities	$ 3,659,506
Fair value of liability for warrant derivative instruments	80,630
Total	3,740,136	$ 1,049,929
Fair Value, Inputs, Level 1 [Member]
Derivative [Line Items]
Embedded conversion option liabilities	0
Fair value of liability for warrant derivative instruments	0
Total	0
Fair Value, Inputs, Level 2 [Member]
Derivative [Line Items]
Embedded conversion option liabilities	0
Fair value of liability for warrant derivative instruments	0
Total	0
Fair Value, Inputs, Level 3 [Member]
Derivative [Line Items]
Embedded conversion option liabilities	3,659,506
Fair value of liability for warrant derivative instruments	80,630
Total	$ 3,740,136

DERIVATIVE FINANCIAL INSTRUME35

DERIVATIVE FINANCIAL INSTRUMENTS and FAIR VALUE MEASUREMENTS (Details 2)	9 Months Ended
	Mar. 31, 2016USD ($)
Balance at Beginning	$ 1,049,929
Effects of foreign currency exchange rate changes	(10,490)
Initial fair value of embedded conversion option derivative liability recorded as debt discount	2,205,925
Initial fair value of embedded conversion option derivative liability recorded as change in fair value of ECO	2,211,529
Change in fair value included in statements of operations	(1,716,757)
Balance at Ending	$ 3,740,136

DERIVATIVE FINANCIAL INSTRUME36

DERIVATIVE FINANCIAL INSTRUMENTS and FAIR VALUE MEASUREMENTS (Details Textual)	Mar. 31, 2016USD ($)$ / sharesshares
Derivative Instruments And Hedging Activities [Line Items]
Class of Warrant or Right, Outstanding	37,569,634
Share Price | $ / shares	$ 0.0304
Repricing option [Member]
Derivative Instruments And Hedging Activities [Line Items]
Convertible Debt | $	$ 2,922,199
Variable conversion pricing [Member]
Derivative Instruments And Hedging Activities [Line Items]
Class of Warrant or Right, Outstanding	3,000,000

SUBSEQUENT EVENTS (Details Text

SUBSEQUENT EVENTS (Details Textual)	May. 02, 2016USD ($)$ / sharesshares	Apr. 14, 2016USD ($)$ / sharesshares	Apr. 12, 2016USD ($)$ / sharesshares	Apr. 07, 2016USD ($)$ / sharesshares	Apr. 05, 2016USD ($)$ / sharesshares	Apr. 04, 2016USD ($)$ / sharesshares	Apr. 01, 2016USD ($)$ / sharesshares	Apr. 30, 2016shares	Apr. 27, 2016USD ($)$ / sharesshares	Apr. 26, 2016USD ($)$ / sharesshares	Apr. 22, 2016USD ($)$ / sharesshares	Apr. 21, 2016USD ($)$ / sharesshares	Apr. 20, 2016USD ($)$ / sharesshares	Apr. 19, 2016USD ($)$ / sharesshares	Apr. 18, 2016USD ($)$ / sharesshares	Mar. 31, 2016USD ($)$ / sharesshares	Mar. 31, 2015USD ($)	Apr. 14, 2016AUD	Jun. 04, 2015$ / shares
Subsequent Event [Line Items]
Debt Instrument, Convertible, Conversion Price | $ / shares																$ 0.03			$ 0.07
Debt Conversion, Converted Instrument, Amount | $																$ 0	$ 152,285
Stock Issued During Period, Shares, Issued for Services																71,500,000
Stock Issued During Period, Value, Issued for Services | $																$ 2,056,059
Stock Issued During Period, Value, Share-based Compensation, Gross | $																$ 4,112,118
Subsequent Event [Member]
Subsequent Event [Line Items]
Percentage of bonus of current salary		66.66%
Accrued Bonuses, Current | AUD																		AUD 200,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		71,500,000
Subsequent Event [Member] | Share-based Compensation Award, Tranche One [Member]
Subsequent Event [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares		23,833,333
Subsequent Event [Member] | Share-based Compensation Award, Tranche Two [Member]
Subsequent Event [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares		23,833,333
Subsequent Event [Member] | Share-based Compensation Award, Tranche Three [Member]
Subsequent Event [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares		23,833,334
Subsequent Event [Member] | Conversion Notice [Member]
Subsequent Event [Line Items]
Debt Conversion, Converted Instrument, Shares Issued	15,531,661		3,870,968	4,398,827	4,105,572	4,398,827	3,189,150		10,695,606	7,560,484	3,425,642	3,780,242	2,059,042	3,855,546	3,855,546
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 0.020925		$ 0.019375	$ 0.01705	$ 0.01705	$ 0.01705	$ 0.01705		$ 0.01463	$ 0.01984	$ 0.01419	$ 0.01984	$ 0.01419	$ 0.0194525	$ 0.0194525
Debt Conversion, Converted Instrument, Amount | $	$ 325,000		$ 75,000	$ 75,000	$ 70,000	$ 75,000	$ 54,375		$ 156,477	$ 150,000	$ 48,610	$ 75,000	$ 29,218	$ 75,000	$ 75,000
Subsequent Event [Member] | Conversion Notice One [Member]
Subsequent Event [Line Items]
Debt Conversion, Converted Instrument, Shares Issued									32,000,000		7,560,484	1,101,335
Debt Instrument, Convertible, Conversion Price | $ / shares									$ 0.01984		$ 0.01984	$ 0.01419
Debt Conversion, Converted Instrument, Amount | $									$ 634,880		$ 150,000	$ 15,628
Subsequent Event [Member] | Conversion Notice Two [Member]
Subsequent Event [Line Items]
Debt Conversion, Converted Instrument, Shares Issued									1,836,534
Debt Instrument, Convertible, Conversion Price | $ / shares									$ 0.01463
Debt Conversion, Converted Instrument, Amount | $									$ 26,868
Subsequent Event [Member] | Chief Executive Officer [Member]
Subsequent Event [Line Items]
Shares Issued, Price Per Share | $ / shares		$ 0.03
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		71,500,000
Subsequent Event [Member] | Consultant [Member]
Subsequent Event [Line Items]
Shares Issued, Price Per Share | $ / shares		$ 0.03
Stock Issued During Period, Shares, Issued for Services		6,250,000						6,250,000			3,750,000
Stock Issued During Period, Value, Issued for Services | $		$ 187,500
Subsequent Event [Member] | Consultant [Member] | Common Stock [Member]
Subsequent Event [Line Items]
Stock Issued During Period, Shares, Issued for Services		6,250,000